Georgia State University

ScholarWorks @ Georgia State University
Biology Dissertations

Department of Biology

4-30-2018

Characterization Of Flavivirus Disease Resistance In Mice And
Comparative Analysis Of Infections With Pathogenic And NonPathogenic Strains Of West Nile Virus In Pluripotent Stem CellDerived Central Nervous System Cells
Joseph C. Madden Jr
Georgia State University

Follow this and additional works at: https://scholarworks.gsu.edu/biology_diss

Recommended Citation
Madden, Joseph C. Jr, "Characterization Of Flavivirus Disease Resistance In Mice And Comparative
Analysis Of Infections With Pathogenic And Non-Pathogenic Strains Of West Nile Virus In Pluripotent
Stem Cell-Derived Central Nervous System Cells." Dissertation, Georgia State University, 2018.
doi: https://doi.org/10.57709/12056811

This Dissertation is brought to you for free and open access by the Department of Biology at ScholarWorks @
Georgia State University. It has been accepted for inclusion in Biology Dissertations by an authorized administrator
of ScholarWorks @ Georgia State University. For more information, please contact scholarworks@gsu.edu.

CHARACTERIZATION OF FLAVIVIRUS DISEASE RESISTANCE IN MICE AND
COMPARATIVE ANALYSIS OF INFECTIONS WITH PATHOGENIC AND NONPATHOGENIC STRAINS OF WEST NILE VIRUS IN PLURIPOTENT STEM CELLDERIVED CENTRAL NERVOUS SYSTEM CELLS

by

JOSEPH C. MADDEN JUNIOR

Under the Direction of Margo A. Brinton, PhD

ABSTRACT
Flaviviruses are arboviruses that can cause neurological disease in mammals. Mice demonstrate
variable susceptibility to flavivirus disease due to inheritance of a single allele, Flvr. Infected mice
that possess Flvr exhibit no symptoms and produce less infectious virus compared to mice with the
susceptible allele Flvs. The product of the Flvr allele, full length 2′-5′ oligoadenylate synthetase 1b
(Oas1b), is part of the host innate immune response and a Type 1 interferon (IFN) stimulated gene
(ISG). The Flvr allele encodes a truncated protein due to a premature stop codon. Cells encode
multiple OAS proteins that exert their antiviral activity by synthesizing short 2′-5′-linked

oligoadenylates that activate RNase L. Oas1b lacks synthetase activity and function as a dominant
negative for the active synthetase Oas1a. However, RNase L was shown to have anti-flavivirus
activity. A line of Oas1b+/+/RNase L-/- mice was generated to analyze the contribution of RNase L
to the Oas1b-mediated flavivirus disease resistance phenotype in vivo. The results indicated that
RNase L is a component of the antiviral response to flaviviruses in mice but is not needed for the
full expression of the Oas1b flavivirus resistance phenotype.
West Nile Virus (WNV) is a neurotropic virus with strains exhibiting varying degrees of
pathogenesis in infected humans. The factors involved in this differential pathogenicity are not
well understood. Using human induced pluripotent stem cells (hiPSCs) differentiated into four
types of CNS cells, infections with pathogenic WNV NY99 or non-pathogenic WNV MAD78
were characterized using traditional virology techniques and also by comparative transcriptome
analysis of infected neural progenitor cells (NPCs) by next generation sequencing. NY99
replicated efficiently in all four CNS cell types and induced cell cycle arrest in NPCs.
Transcriptome analysis of astrocytes infected by NY99 revealed robust activation of inflammatory
response in these cells. MAD78 infected NPCs as efficiently as NY99 but infected astrocytes less
efficiently than WNV NY99. Infection of astrocytes by both viruses induced secretion of proinflammatory cytokines. Transcriptome analysis of infected NPCs revealed that infections with
both viruses induced the expression of viral defense genes, ER stress genes, and inhibited neuronal
development.

INDEX WORDS: WNV, flavivirus, inherited flavivirus disease resistance, RNase L, oas1b,
pluripotent stem cells, RNAseq, Zika virus

CHARACTERIZATION OF FLAVIVIRUS DISEASE RESISTANCE IN MICE AND
COMPARATIVE ANALYSIS OF INFECTIONS WITH PATHOGENIC AND NONPATHOGENIC STRAINS OF WEST NILE VIRUS IN PLURIPOTENT STEM CELLDERIVED CENTRAL NERVOUS SYSTEM CELLS

by

JOSEPH C. MADDEN JUNIOR

A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of
Doctor of Philosophy
in the College of Arts and Sciences
Georgia State University
2018

Copyright by
Joseph Compton Madden Junior
2018

CHARACTERIZATION OF FLAVIVIRUS DISEASE RESISTANCE IN MICE AND
COMPARATIVE ANALYSIS OF INFECTIONS WITH PATHOGENIC AND NONPATHOGENIC STRAINS OF WEST NILE VIRUS IN PLURIPOTENT STEM CELLDERIVED CENTRAL NERVOUS SYSTEM CELLS

by
JOSEPH MADDEN JUNIOR

Committee Chair:

Margo Brinton

Committee:

Margo Brinton

Phillip Santangelo
Deborah Baro

Electronic Version Approved:

Office of Graduate Studies
College of Arts and Sciences
Georgia State University
May 2018

iv

DEDICATION
I dedicate this dissertation to my late aunt Kathy Sutton. I was very fortunate to have an aunt like
her who was really more like a second grandmother. She was always excited about having a doctor
in the family and was always supportive, caring and accepting. I will miss her very much, and I
know that she would have been proud of me. To my late grandmother Elain Dowis who always
encouraged me to pursue intellectual curiosity and to read as much as I could. I want to dedicate
this dissertation to my beloved wife Han Di who always motivated me and stood by my side during
all the hard times and provided me with wisdom and guidance in times of uncertainty. Last but not
least my parents Joe & Peggy Madden. They have been so supportive and excited throughout my
PhD journey. I love all of you and thank you for everything!

ii

ACKNOWLEDGEMENTS
I would like to thank my mentor Dr. Margo Ann Brinton for her guidance during my time as a
PhD candidate. She is an amazing woman who has accomplished so much and I am very lucky to
have had her as a mentor. I want to thank her for always being willing to help and to teach me and
for her endless patience as well. I want to thank my committee members Dr. Deborah Baro and
Dr. Philip Santangelo for their insight and expertise in imaging technology and neuronal biology.
I want to thank Zhexing Wen for his training for working with stem cells. It is a valuable tool! I
want to thank Emilio Espinola for his help with analyzing the RNA-seq data. I want to thank Fred
Ede for his assistance in all things tissue cultures and his companionship. I want to thank all the
members of the Brinton lab past and present who trained me and gave me support! Thanks to you
all!

iii

TABLE OF CONTENTS

ACKNOWLEDGEMENTS ............................................................................................................ ii
LIST OF FIGURES ...................................................................................................................... vii
LIST OF TABLES ......................................................................................................................... ix
LIST OF ABBREVIATIONS ......................................................................................................... x
1

INTRODUCTION .................................................................................................................. 1
Flaviviruses ................................................................................................................................. 1
WNV Pathogenesis in Humans ................................................................................................... 2
WNV Life Cycle ......................................................................................................................... 3
Flavivirus Nonstructural Proteins ............................................................................................... 6
Cellular innate immune response to A virus infection................................................................ 9
Inherited flavivirus disease resistance ...................................................................................... 10
Oas1b-mediated flavivirus disease resistance ........................................................................... 10
The OAS/RNase L pathway...................................................................................................... 11
GOALS OF THIS DISSERTATION........................................................................................ 12
Specific Aim 1: Characterization of components of the Oas1b-mediated flavivirus disease
resistance phenotype in mice ................................................................................................ 12
Specific Aim 2: Characterization of the response of human induced pluripotent stem cellderived CNS cells to infection with pathogenic and nonpathogenic strains of WNV. ......... 13

2

SPECIFC AIM 1: CHARACTERIZATION OF OAS1B MEDIATED DISEASE

FLAVIVIRUS DISEASE RESISTANCE IN MICE .................................................................... 14

iv

Introduction ............................................................................................................................... 14
Materials And Methods............................................................................................................. 16
Generation of an Oas1b+/+/RNase L-/- mouse strain.............................................................. 16
Cells and viruses. .................................................................................................................. 17
Mouse infection protocols..................................................................................................... 18
Analysis of infectious virus, viral RNA and ISG mRNA levels in the brains of infected mice.
............................................................................................................................................... 18
Immunofluorescence assay (IFA) of brain tissue. ................................................................ 20
Results ....................................................................................................................................... 21
Resistant mice lacking RNase L survive lethal doses of WNV and YFV. ........................... 21
WNV production in the brains of resistant mice that express or lack RNase L. .................. 23
Comparison of the levels of WNV genome RNA in the brains of resistant mice that express
or lack RNase L. ................................................................................................................... 25
Analysis of the Type 1 interferon response in the brains of resistant mice that express or lack
RNase L ................................................................................................................................ 27
Analysis of flavivirus RNA replication in mouse brain cells by IFA. .................................. 29
Discussion ................................................................................................................................. 32
3

SPECIFIC AIM 2: CHARACTERIZATION OF THE RESPONSE OF HUMAN

PLURIPOTENT STEM CELL-DERIVED CNS CELLS TO INFECTION WITH AVIRULENT
AND VIRULENT STRAINS OF WNV....................................................................................... 35
Introduction ............................................................................................................................... 35

v

Materials And Methods............................................................................................................. 38
Cells and viruses ................................................................................................................... 38
Infection protocol .................................................................................................................. 39
Immunofluorescence Assay .................................................................................................. 40
Western Blotting ................................................................................................................... 40
Cellular RNA extraction ....................................................................................................... 41
RNA-seq and Transcriptome Analysis ................................................................................. 42
Cell counting ......................................................................................................................... 43
BrdU pulse-chase .................................................................................................................. 43
Quantification of secreted pro-inflammatory cytokines ....................................................... 44
Results ....................................................................................................................................... 44
WNV strain NY99 can efficiently infect four types of hiPSC-derived CNS cells ............... 44
NY99 infection leads to caspase-3-dependent apoptosis in CNS cells................................. 46
Analysis of the effects of antiviral compounds on WNV NY99 replication in NPCs and in
astrocytes............................................................................................................................... 49
Comparison of the efficiency of infections with WNV MAD78 and NY99 in NPCs and
astrocytes............................................................................................................................... 53
Transcriptome analysis of NPCs infected with either WNV MAD78 or NY99................... 55
WNV infection of CNS cells modulates the cell cycle and decreases cell proliferation ...... 61
Astrocytes infected with WNV NY99 express pro-inflammatory cytokine genes ............... 72

vi

Discussion ................................................................................................................................. 74
4

CONCLUSIONS AND FUTURE DIRECTIONS................................................................ 80
Characterization of components of flavivirus disease resistance in mice............................. 80
Characterization of the response of human pluripotent stem cell-derived CNS cells to
infection with avirulent and virulent strains of WNV .......................................................... 82

5

REFERENCES ..................................................................................................................... 85

vii

LIST OF FIGURES
Figure 2.1 Survival curves for mice infected intracranially with a flavivirus.. ............................ 22
Figure 2.2. Infectious virus yields in brains of flavivirus resistant and flavivirus susceptible mice
infected with WNV. ...................................................................................................................... 24
Figure 2.3. RNA production in the brains of susceptible and resistant mice infected with WNV. 26
Figure 2.4. Upregulation of IFN and Oas1 mRNA expression in the brains of susceptible and
resistant mice infected with WNV. ............................................................................................... 28
Figure 2.5. Level of dsRNA staining in the brains of resistant and susceptible mice following
infection with WNV NY99. .......................................................................................................... 30
Figure 2.6. Level of dsRNA staining in the brains of resistant and susceptible mice following
infection with YFV-17D.. ............................................................................................................. 31
Figure 3.1. NY99 infection in four hiPSC-derived CNS cell types. ............................................. 45
Figure 3.2. NY99 infection causes caspase-3-dependent cell death in NPCs and neurons. ......... 48
Figure 3.3. Analysis of the effect of Niclosamide or PHA-690509 treatment of NY99 infected
NPCs on WNV replication............................................................................................................ 50
Figure 3.4. Analysis of the effect of Niclosamide or PHA-690509 treatment of NY99 infected
astrocytes on WNV replication. .................................................................................................... 52
Figure 3.5. MAD78 infection in hiPSC-derived NPCs and astrocytes. ........................................ 54
Figure 3.6. Comparative transcriptome analysis at 12 hpi of NPCs infected with NY99 or MAD78.
....................................................................................................................................................... 56
Figure 3.7. Comparative transcriptome analysis at 24 hpi of NPCs infected with NY99 or MAD78
....................................................................................................................................................... 59

viii

Figure 3.8. Protein-protein interaction network analysis of cell cycle-related DEGs during
infection of NPCs by NY99.. ........................................................................................................ 65
Figure 3.9. Inhibition of CNS cell proliferation by a NY99 infection. ......................................... 66
Figure 3.10. Analysis by BrdU pulse-labeling of DNA synthesis in SNB-19 cells infected with
NY99.. ........................................................................................................................................... 69
Figure 3.11. Effect of cell cycle arrest on WNV infection of SNB-19 cells. ............................... 71
Figure 3.12. Transcriptome analysis of hiPSC-derived astrocytes infected with NY99. ............. 73
Figure 3.13. WNV infected astrocytes produce pro-inflammatory cytokines. ............................. 75

ix

LIST OF TABLES
Table 3.1. List of DEGs that were upregulated by NY99 infection in NPCs ............................... 62
Table 3.2. List of DEGs that were downregulated by NY99 infection in NPCs .......................... 62

x

LIST OF ABBREVIATIONS
Zika virus (ZIKV)
Dengue virus (DENV)
Yellow fever virus (YFV)
West Nile virus (WNV)
The Centers for Disease Control and Prevention (CDC)
blood-brain barrier (BBB)
central nervous system (CNS)
endoplasmic reticulum (ER)
unfolded protein response (UPR)
viral envelope protein (E)
viral membrane protein (M)
non-structural protein (NS)
viral capsid protein (C)
single stranded RNA (ssRNA)
messenger RNA (mRNA)
open reading frame (ORF)
poly(A)-binding protein (PABP)
non-coding region (NCR)

xi

cyclization sequences (CYC)
double stranded RNA (dsRNA)
replicative intermediate (RI)
replication complex (RC)
convoluted membranes (CM)
replication vesicles (RV)
interferon (IFN)
signal transducers and activators of transcription 1 (STAT1)
IFN stimulated gene (ISG)
hours post infection (hpi)
nucleoside triphosphatase (NTPase)
RNA 5′-triphosphatase (RTPase)
methyltransferase (MTase)
RNA-dependent RNA polymerase (RdRp)
pathogen associated molecular pattern (PAMP)
pattern recognition receptor (PRR)
Retinoic acid inducible gene I (RIG-I)-like receptors (RLR)
IFN regulatory factor (IRF)

xii

IFNα/β receptor complex (IFNAR)
activate tyrosine kinase 2 (TYK2)
Janus kinase 1 (JAK1)
intracerebral/intracranial (IC)
subcutaneous (SC)
intraperitoneal (IP)
Flavivirus-resistance allele, resistant form (Flvr)
Flavivirus-resistance allele, susceptible form (Flvs)
C3H Heston mouse strain (C3H/He)
Congenic Heston strain with the Flvr (C3H/RV)
mouse embryonic fibroblast (MEF)
2′-5′ linked oligoadenylate (2-5A)
2′,5′-oligoadenylate synthetase (OAS) 1b (Oas1b)
2′,5′-oligoadenylate synthetase 1b (Oas1b)
Oas1b truncated form (Oas1bt)
ATP-binding cassette subfamily f member 3 (ABCF3)
oxysterol binding protein-related protein 1L (Orp1L)
human induced pluripotent stem cell (hiPSC)

xiii

neural progenitor cell (NPC)
endogenous latent ribonuclease (RNase L)
baby hamster kidney (BHK)
fetal bovine serum (FBS)
Hank’s balanced salt solution (HBSS)
minimal essential medium (MEM)
real time quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
immunofluorescence assay (IFA)
paraformaldehyde (PFA)
normal horse serum (NHS)
days post infection (dpi)
subventricular zone (SVZ)
hippocampal dentate gyrus (DG)
C-X-C motif chemokine 10 (CXCL10)
interleukin 6 (IL-6)
C-C motif chemokine 5 (CCL5)
tumor necrosis factor alpha (TNF-α)

xiv

pre-mitotic neuron (PMN)
post-mitotic neuron (MN)
next generation sequencing (NGS)
global transcriptome analysis (RNA-seq)
tris-buffered saline (TBS)
tris-buffered saline with Tween-20 (TBS-T)
paired-end (PE)
differential expression (DE)
differential expressed gene (DEG)
database for annotation, visualization and integrated discovery (DAVID)
enzyme-linked immunosorbent assay (ELISA)
microtubule-associated protein kinase 2 (MAP2)
chicken ovalbumin upstream promoter-interacting protein 2 (CTIP2)
cleaved caspase 3 (Casp3+)
dimethyl sulfide (DMSO)
cyclin-dependent kinase (CDK)
minichromosome maintenance complex (MCM)
cyclin-dependent kinase inhibitor 1a (CDKN1A)

xv

glioblastoma cell line (SNB-19)
propidium iodide (PI)
hours post release (hpr)
aphidicolin (APH)
xbox-binding protein 1 (XBP1)
Hepatits C virus (HCV)

1

1

INTRODUCTION

FLAVIVIRUSES
Arboviruses are maintained in natural transmission cycles consisting of hemataphageous
arthropods and vertebrate hosts. Arboviruses of the genus Flavivirus in the family Flaviviridae
include important human pathogens such as Zika virus (ZIKV), dengue virus (DENV), yellow
fever virus (YFV) and West Nile virus (WNV) (Lindenbach, Murray et al. 2013). All members of
the genus Flavivirus have a single-stranded positive sense RNA genome with the same gene
organization but differ in some of the cis-acting RNA regulatory elements (Brinton 2014).
Although flaviviruses are primarily found in tropical regions throughout the world, their
distribution has expanded in the 21st century due to broadening mosquito ranges, to increases in
human population density, and to increases in worldwide travel (Lindenbach, Murray et al. 2013).
West Nile virus was first isolated in Uganda in the early twentieth century (Suthar,
Diamond et al. 2013). WNV is spread by mosquitoes and is maintained in nature via a transmission
cycle between small birds and mosquitoes with humans and horses as dead-end hosts. Sequence
analysis of the genomes of WNV isolates has revealed two main lineages. Lineage 1 viruses are
found throughout the world including in the Americas, the Middle East, Europe, India and
Australia (Lanciotti, Ebel et al. 2002). Lineage 2 viruses are primarily found in Africa but recent
evidence suggests that some of these viruses have spread to Europe (Erdelyi, Ursu et al. 2007).
While most outbreaks of disease in humans were due to lineage 1 viruses, both lineages include
pathogenic and non-pathogenic members (Brinton 2014). WNV infection in humans typically
causes no symptoms or a mild febrile illness but can occasionally cause serious neurological
pathology (Lindenbach, Murray et al. 2013). The Centers for Disease Control and Prevention
(CDC) reported in 2012 that there were 5,674 documented cases of WNV disease with 51%
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causing neuroinvasive disease and a mortality rate of 5%. The actual number of WNV infected
individuals is likely higher due to either lack of symptoms or non-reporting of symptoms (Centers
for Disease and Prevention 2013). There is emerging evidence that resolution of WNV infection
of the CNS may have prolonged negative effects on neurological health (Garber, Vasek et al.
2018).
WNV PATHOGENESIS IN HUMANS
WNV replicates in the midgut cells and salivary glands of Culex mosquitoes and is spread
to other hosts during mosquito feeding. In humans, the virus initially replicates in cells of the
epidermis including antigen-presenting Langerhans cells (Suthar, Diamond et al. 2013). Infected
Langerhans cells can migrate to draining lymph nodes, facilitating spread of the virus to the lymph
nodes, then to the blood, and then to organs including the spleen, liver, and kidneys (Johnston,
Halliday et al. 2000). In some humans infected with some strains of WNV, the virus crosses the
blood-brain barrier (BBB) and enters the central nervous system (CNS). The BBB is comprised of
the endothelial cells which line the blood vessels in the brain and foot processes of astrocytes
which wrap around the blood vessels and form tight junctions to prevent free movement of
molecules into the CNS (Daneman and Prat 2015). The factors involved in neuroinvasion by some
strains of WNV and not others are not well understood (Hussmann, Samuel et al. 2013, Suthar,
Diamond et al. 2013). Once in the CNS, neurons appear to be the primary targets of WNV
infection. Cell death occurs through caspase 3-dependent apoptosis (Samuel, Morrey et al. 2007).
Neurons are classified into several different subtypes based on their location and function in the
brain. The ability of viruses to infect these different neuron subtypes can have a large impact on
inflammation in the CNS due to differing activation of and sensitivity to host antiviral defense
responses (Cho, Proll et al. 2013). Infected neurons express CXCL10 and other pro-inflammatory
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cytokines that result in recruitment of T cells and other infiltrating cells to the CNS and may also
facilitate the BBB becoming leaky through the activity of matrix metalloproteinases (Samuel and
Diamond 2009). CNS cells infected with WNV demonstrate endoplasmic reticulum (ER) stress
that can lead to apoptosis through activation of the unfolded protein response (UPR) (Medigeshi,
Lancaster et al. 2007). Glial cells such as astrocytes can become activated following CNS
infection, leading to secretion of pro-inflammatory cytokines such as TNF-α and IL-6 (Cho and
Diamond 2012).
WNV LIFE CYCLE
WNV virions are 50 nm in diameter and have an envelope membrane that contains the viral
envelope (E) protein and membrane (M) proteins. The E proteins form head-to-tail homodimers
that lie flat against the membrane and form a smooth quasi-icosahedral shell. The nucleocapsid is
composed of capsid (C) protein dimers that have hydrophobic regions for interaction with the
cytoplasmic face of the ER membrane and charged regions that likely interact with the viral RNA
(Lindenbach, Murray et al. 2013). In culture, WNV can infect primary cells and cell lines from
many different host species, including mammalian, avian, and insects. The viral E protein attaches
to an unknown receptor at the cell surface and virions in clathrin-coated pits enter the cell via the
endosomal pathway (Brinton 2014). The increasing acidity of early endosomes triggers a
conformational rearrangement of the E protein that mediates fusion of the virion membrane with
the cell endosomal membrane. This facilitates release of the viral genome into the cytoplasm
(Lindenbach, Murray et al. 2013). Flavivirus genomes are single stranded RNA (ssRNA) of about
11 kb in length with a 5′ cap but no 3′ poly(A) tail. The viral genome acts as a messenger RNA
(mRNA). It contains a single open reading frame (ORF) that can immediately be used to translate

4

the viral polyprotein. The viral polyprotein is cleaved by viral and host proteases into 3 structural
and 7 non-structural proteins (Brinton 2014).
Translation of the viral polyprotein from the genomic RNA occurs in the cytoplasm of the
infected cell. The efficiency of viral protein translation appears to be a major determinant of
virulence, yet the mechanisms of viral translation outcompeting cellular translation are poorly
understood (Edgil, Diamond et al. 2003). Mosquito-borne flaviviruses utilize cap-dependent
translation but have been shown to be able to use cap-independent methods as well (Edgil, Polacek
et al. 2006, Villas-Boas, Conceicao et al. 2009, Perez Dominguez, Rojas et al. 2015). Despite not
having a poly(A) tail, the 3′-NCR of a mosquito-borne flavivirus genomic RNA can bind poly(A)binding protein (PABP). This interaction may enhance cap-dependent translation of the viral
polyprotein through facilitating interaction of the 3′ end of the genome with the 5′ cap binding
proteins (Polacek, Friebe et al. 2009). The viral structural proteins C, E and M are encoded in the
5′-end of the genome while the nonstructural proteins NS1, NS2A, NS2B, NS3, NS4A, NS4B and
NS5 are encoded in the 3′ region (Lindenbach, Murray et al. 2013). The viral polyprotein is cleaved
to the mature proteins by the viral protease complex, NS2B-NS3, and by the activity of cellular
proteases. The viral non-structural proteins are all required for viral RNA replication and also have
additional functions in the cell during infection (Brinton 2014).
The coding region of a flavivirus genome is flanked by non-coding regions (NCRs) that
contain several cis-acting secondary structural elements. Cyclization sequences (CYC) and
flanking sequences in the 3′ and 5′ NCRs are essential for the long-distance RNA-RNA interactions
that regulate the switch from viral protein translation to negative sense (-)RNA synthesis
(Khromykh, Meka et al. 2001, Lo, Tilgner et al. 2003). The NCRs can also bind to host proteins
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that are important for viral replication and protect viral genomes from digestion by
exoribonucleases (Lindenbach, Murray et al. 2013).
Flavivirus RNA replication is semiconservative and asymmetric. Following cyclization of
the genome, a single complementary (-)RNA is synthesized from the genome that then serves as
the template for the synthesis of new genomes. In infected cells, the viral RNA is primarily found
in three distinct forms: single-stranded plus strand (+)RNA, double stranded RNA (dsRNA)
replicative form consisting of a positive and negative strand RNA and replicative intermediate (RI)
RNA made up of a (-)RNA strand and multiple (+)RNA strands. Early in the replication cycle,
the amount of minus and plus strand RNA is approximately equal but at later times more than a
10-fold accumulation of plus strand over minus strand is detected in infected cells (Brinton 2014).
Viral genomes are replicated by replication complexes (RCs) formed by all of the viral
nonstructural proteins. Substantial cytoplasmic membrane proliferation and rearrangement occurs
in infected cells and convoluted membranes (CM) are concentrated around the nucleus in areas of
viral RNA replication. At early times post infection the reinitiation of (+)RNA strand synthesis
from the (-)RNA template is inefficient. At later times post infection, (+)RNA synthesis becomes
very efficient and nascent viral genomic RNA is produced at an exponential rate (Brinton 2014).
The switch to exponential (+)RNA transcription coincides with the appearance of invaginations of
the endoplasmic reticulum (ER) called replication vesicles (RV) that contain the RC and viral
dsRNA. Newly synthesized (+)RNA strands exit these RVs into the cytoplasm through a small
pore and are either translated, transcribed to make new (-)RNA templates or are assembled into
virions (Welsch, Miller et al. 2009, Brinton 2014).
The exact mechanism of viral genomic RNA encapsidation is not well understood but it
appears that interaction of genomic RNA with C proteins that line the cytoplasmic face of the ER
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in areas that contain preM and E leads to viral progeny budding into the ER lumen (Welsch, Miller
et al. 2009, Brinton 2014). The preM and E proteins extend into the ER lumen as heterodimers that
associate into trimers. The preM protein assists with proper folding of the E protein and prevents
premature acid-catalyzed rearrangement of the E protein (Mukhopadhyay, Kuhn et al. 2005).
Immature virions accumulate in the ER lumen and are transported through the Golgi apparatus
(Welsch, Miller et al. 2009). As part of virus maturation the cell protease furin cleaves preM to M,
which then allows the E proteins to undergo a conformational change to form head to tail
homodimers that lie flat against the viral envelope (Lindenbach, Murray et al. 2013). Mature
virions are exocytosed at the plasma membrane. Progeny virus can be detected exiting an infected
cell by 8 to 10 hours after infection (Brinton 2014).
FLAVIVIRUS NONSTRUCTURAL PROTEINS
The nonstructural proteins NS2A, NS2B, NS4A and NS4B each contain multiple
membrane-spanning domains that anchor them in the ER membrane. NS2A is a 20 kD
hydrophobic protein that is located in the RVs where it interacts with NS3, NS5, the 3′-NCR of
the genome and also has been shown to play a role in virus assembly (Lindenbach, Murray et al.
2013). In human cells dengue virus and WNV NS2A can antagonize Type I interferon (IFN)
signaling by inhibiting signal transducers and activators of transcription 1 (STAT1)
phosphorylation in the JAK/STAT signaling pathway and blocking IFN stimulated gene (ISG)
induction (Cumberworth, Clark et al. 2017). It may also contribute to IFN-independent apoptosis
and virulence in mice (Melian, Edmonds et al. 2013). NS2B is a co-factor for the NS3 protease
and is essential for viral protease activity (Erbel, Schiering et al. 2006).
NS4A and NS4B are small (16 kDa and 27 kDa, respectively) hydrophobic proteins that
are connected by a 2K linker. Both proteins colocalize with dsRNA and NS3 in infected cells,
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indicating that they are in the RVs (Lindenbach, Murray et al. 2013). Expression of NS4A-2K
alone or coexpression of NS4A-2K-NS4B together with the NS2B-NS3 protease induced
cytoplasmic membrane rearrangement in mammalian cells (Roosendaal, Westaway et al. 2006).
NS4A and NS4B from mosquito-borne flaviviruses can block the Type 1 IFN response at multiple
steps in the pathway following 2K cleavage. Of the two, the Type 1 IFN-antagonist activity of
NS4B appears to be more robust and more highly conserved (Chen, Wu et al. 2017).
NS1 is a 46 kDa glycoprotein found associated with RCs in the ER lumen of infected cells
and also at the plasma membrane (Lindenbach, Murray et al. 2013). NS1 is hydrophilic but in cells
it can form homodimers that have an affinity for membranes. The N-glycosylation residues in NS1
have been shown to be crucial for RNA replication (Brinton 2014). RNA replication deficient
mutants of YFV with large deletions in NS1 were able to replicate viral RNA when NS1 was
supplied in trans, indicating that it may function in the initiation of viral RNA replication
(Khromykh, Sedlak et al. 1999). NS1 is secreted from infected cells as hexamers starting at 16
hours post infection (hpi) and protects virions by antagonizing the complement anti-microbial
pathway. (Brinton 2014). NS1 directly interacts with complement components H, C1 and C4, and
these interactions are facilitated by glycosylation at several key residues on the protein. Mutation
of these residues has little effect on viral replication in mammalian cell cultures but dramatically
decreases neuroinvasiveness, neurovirulence and viremia in mice (Whiteman, Li et al. 2010).
NS3 is a 70 kDa protein with a wide range of important functions. The N-terminal region
is a serine protease that requires NS2B as a co-factor. This viral protease cleaves the polyprotein
at adjacent basic residue sites at the NS2A/NS2B, NS2B/NS3, NS3/NS4A and NS4B/NS5
junctions and cleaves at the C-terminus of the C protein (Lindenbach, Murray et al. 2013).
Membrane association is required for protease activity and is likely facilitated through interaction
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with the membrane bound NS2B. The C-terminal region of NS3 has helicase, nucleoside
triphosphatase (NTPase), and RNA 5′-triphosphatase (RTPase) activities that are all stimulated by
the presence of RNA (Brinton 2014). A highly conserved Walker B motif found in the helicase
domain is crucial for all three of these functions (Benarroch, Selisko et al. 2004). After binding to
ssRNA, the NS3 protein undergoes a conformational change that facilitates ATP hydrolysis to
drive helicase activity (Brinton 2014). Interestingly, DENV NS3 can anneal complementary RNA
strands in the absence of ATP, suggesting that the concentration of ATP may serve a regulatory
role for NS3 switching between annealing and unwinding of the viral RNA (Gebhard, Kaufman et
al. 2012). NS4A is a co-factor for helicase activity (Shiryaev, Chernov et al. 2009). NS3 RTPase
activity is non-specific and can act on any 5′ RNA terminus. This activity is a necessary first step
for 5′-capping of the viral genome. The expression of NS3 alone can induce caspase-8-dependent
apoptosis in cells (Lindenbach, Murray et al. 2013).
NS5 is a large 103 kDa protein that is the most conserved of all the flavivirus proteins. Its
N-terminal domain has guanyltransferase and methyltransferase (MTase) activities. NS5 performs
N-7 methylation and 2′-O methylation of the viral genome RNA 5′-terminus in conjunction with
NS3 RTPase activity (Brinton 2014). Both the N7 and 2′-O MTase activities of NS5 are necessary
for virus replication and innate immune evasion (Lindenbach, Murray et al. 2013). The C-terminal
domain of NS5 has conserved RNA-dependent RNA polymerase (RdRp) motifs that are found in
the polymerases of many plus strand RNA viruses. In vitro RdRp activity has been demonstrated
for purified NS5 from WNV, JEV and DENV (Lindenbach, Murray et al. 2013). Mutation of the
highly conserved GDD sequence ablates WNV NS5 RdRp activity (Guyatt, Westaway et al. 2001).
Characterization of the DENV NS5 RdRp activity revealed that genome cyclization due to the
presence of both CYC sequences was necessary for de novo initiation of (-)RNA synthesis
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although RNAs with complementary mutant 3′ and 5′ CYC sequences also worked as templates
(Ackermann and Padmanabhan 2001). Despite the critical role of NS5 in RNA replication, some
NS5 translocates to the nucleus due to having two functional nuclear localization signals. In the
nucleus it likely plays a role in antagonizing the innate immune response in infected cells (Best,
Morris et al. 2005, Pryor, Rawlinson et al. 2007, Ye, Chen et al. 2017).
CELLULAR INNATE IMMUNE RESPONSE TO A VIRUS INFECTION
Mammalian cells counteract viral infection in neurons and other cells through the activity
of Type 1 IFNs (Samuel and Diamond 2005). IFN expression is activated following detection of
pathogen associated molecular patterns (PAMPs) by host cell pattern recognition receptors (PRRs)
found at the plasma membrane, in endosomal compartments and in the cytoplasm (Suthar, Aguirre
et al. 2013). TLRs found in endosomes can detect both ssRNA and dsRNA from incoming viruses
(Kawai and Akira 2007). Retinoic acid inducible gene I (RIG-I)-like receptors (RLRs) are found
in the cytoplasm and detect dsRNA such as viral replicative intermediates or secondary RNA
structures (Loo, Fornek et al. 2008). Following PRR binding to PAMPs, downstream effectors
activate transcription factors, including IFN regulatory factor (IRF) -3 and -7 and nuclear factor
kappa B (NF-κB), that leads to production and secretion of Type I IFNs. Secreted Type I IFNs
bind to the IFNα/β receptor complex (IFNAR) and activate tyrosine kinase 2 (TYK2) and Janus
kinase 1 (JAK1) to phosphorylate STAT proteins. Phosphorylated STAT-1 and STAT-2 form a
complex with IRF-9 that translocates to the nucleus and binds to interferon-stimulated response
elements (ISREs) in the promoters of ISGs, activating their expression and creating an antiviral
state (Suthar, Diamond et al. 2013). The activities of several ISGs have been implicated in
contributing to survival of a flavivirus infection by mice (Samuel, Whitby et al. 2006).
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INHERITED FLAVIVIRUS DISEASE RESISTANCE
Mice with a single autosomal dominant allele (Flvr) are resistant to lethal doses of
flavivirus after intracerebral (IC), subcutaneous (SC), or intraperitoneal (IP) inoculation. This
resistance does not extend to viruses outside of the genus Flavivirus. Flvr mice are susceptible to
infection by flaviviruses but develop no detectable symptoms (Shellam, Sangster et al. 1998). Flvr
mice produce lower titers of virus than susceptible mice (Flvs) indicating that virus replication is
suppressed (Brinton, Arnheiter et al. 1982, Urosevic, van Maanen et al. 1997). Mouse embryonic
fibroblasts (MEFs) derived from Flvr mice also produce lower yields of virus than those from Flvs
mice, although the difference in titer is less dramatic than in mice (Brinton, Arnheiter et al. 1982).
The resistance phenotype demonstrates an autosomal dominant mode of inheritance. Congenic
mice homozygous for Flvr (C3H/RV) were generated from susceptible mice (C3H/He) by breeding
C3H/He mice with the resistant PRI strain followed by 9 rounds of backcrossing progeny to
C3H/He mice and then selecting the progeny for further breeding at each round by screening for
flavivirus disease resistance (Brinton and Perelygin 2003).
OAS1B-MEDIATED FLAVIVIRUS DISEASE RESISTANCE
The Flvr phenotype is conferred by a single gene, 2′,5′-oligoadenylate synthetase (OAS)
1b (Oas1b) (Perelygin, Scherbik et al. 2002). Due to the presence of a premature stop codon, the
product of the susceptible allele of Oas1b (Oas1bt) is missing the C-terminal region that contains
a transmembrane domain. Using a homologous recombination strategy, the C-terminal sequence
from a resistant mouse was knocked into the susceptible allele in C57BL/6 mice and the
homozygous Oas1b-KI mouse strain was generated. These mice are resistant to flavivirus-induced
disease (Scherbik, Kluetzman et al. 2007).
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THE OAS/RNASE L PATHWAY
Oas1b is an ISG and a member of the OAS family of host antiviral proteins (Kakuta,
Shibata et al. 2002). Humans have OAS1, OAS2, OAS3 and OASL genes. Mice, in addition to
having OAS2 and OAS3 and two copies of OASL, have eight Oas1 genes (Oas1a-Oas1h). OAS
proteins detect incoming pathogens such as viruses by sensing dsRNA (Donovan, Dufner et al.
2013). Upon activation, OAS proteins polymerize ATP generating short 2′-5′ linked
oligoadenylates (2-5A) that activate the cytosolic endoribonuclease RNase L. RNase L then nonspecifically degrades single-stranded RNAs, including viral RNAs (Silverman 2007).
The canonical OAS/RNase L pathway has an antiviral effect on flavivirus replication but
it is not as robust as the inhibitory effect of Oas1b (Scherbik, Paranjape et al. 2006). Oas1b is an
inactive synthetase that has also been shown to inhibit Oas1a 2-5A production in vitro and in vivo
by acting as a dominant negative (Elbahesh, Jha et al. 2011). This dominant negative effect would
be expected to increase rather than decrease virus yield. However, while infected resistant MEFs
expressing a dominant negative form of RNase L showed some increase in virus yield, the levels
were still lower than those in susceptible cells with RNase L activity unimpeded (Scherbik,
Paranjape et al. 2006). The flavivirus specific nature of Oas1b-mediated viral inhibition may in
part be due to its transmembrane domain which was shown to target it to the ER where the (+)RNA
producing RVs are located. The susceptible Oas1bt is C-terminally truncated and lacks the
transmembrane domain (Courtney, Di et al. 2012). The flavivirus inhibitory activity also appears
to be mediated by its two binding partners, ATP-binding cassette subfamily f member 3 (ABCF3)
and oxysterol binding protein-related protein 1L (Orp1L) (Courtney, Di et al. 2012).
ABC genes are a large family of conserved transporter proteins. They have a conserved
ATP-binding domain made up of Walker A and Walker B motifs and also a third motif, C, that is
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unique to ABC proteins (Schriml and Dean 2000). The precise functions of ABCF3 in mammalian
cells are not known. ABCF3 interacts with Oas1b, Oas1bt and a mutant form of Oas1b that was
missing only its transmembrane domain (Oas1bΔTM). RNAi-mediated reduction of ABCF3 levels
in cells resulted in increased production of WNV in resistant MEFs but had no effect on the
replication of other types of RNA viruses or on WNV replication in susceptible MEFs (Courtney,
Di et al. 2012).
Orp1L is a cholesterol-sensing protein that is involved in targeting late endosomes to the
ER membrane and regulates cholesterol transport from late endosomes/lysosomes to the ER
(Rocha, Kuijl et al. 2009, Zhao and Ridgway 2017). Knockdown of Orp1L decreased flavivirus
production in Oas1b+/+ MEFs, but this result was not specific to flaviviruses, and was believed to
be due to the involvement of Orp1L in the regulation of endosomes, which are required for virus
entry. Orp1L did not interact with Oas1bt but did interact with Oas1bΔTM indicating that its
interaction region is located between the end of Oas1bt and the beginning of the transmembrane
domain (Courtney, Di et al. 2012).

GOALS OF THIS DISSERTATION
Specific Aim 1: Characterization of components of the Oas1b-mediated flavivirus disease
resistance phenotype in mice
Flavivirus disease resistance in mice is due to inheritance of the Flvr allele, which encodes
Oas1b, a full length, inactive 2-5A synthetase that has a dominant negative effect on an active
Oas1 synthetase, Oas1a (Elbahesh, Jha et al. 2011). RNase L, the 2-5A downstream effector, is an
endonuclease that cleaves cell and viral ssRNA. Oas1b is one member of a family of OAS proteins.
OAS protein expression is upregulated by Type 1 IFN signaling, which is activated by a flavivirus
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infection. Previous studies showed that RNase L has anti-flavivirus activity and that It can cleave
flavivirus genome RNA. Whether RNase L activity contributes to the flavivirus resistance
phenotype in mice will be analyzed and the characteristics of this resistance phenotype will be
further investigated.
Specific Aim 2: Characterization of the response of human induced pluripotent stem cellderived CNS cells to infection with pathogenic and nonpathogenic strains of WNV.
The majority of infections with WNV in humans are asymptomatic but occasionally WNV
infection can cause serious CNS disease with the potential for long term complications following
resolution of the infection (Winkelmann, Luo et al. 2016). Comparison of the differential response
of pathogenic and nonpathogenic strains of WNV in different types of human CNS cells may
provide insight into the molecular mechanisms involved in WNV encephalitic disease induction
and outcome. The responses to pathogenic WNV strain NY99 and the nonpathogenic WNV strain
MAD78 infections of human induced pluripotent stem cells (hiPSCs) differentiated into neural
progenitor cells (NPCs) and of NPCs differentiated into neurons or astrocytes will be analyzed.
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2

SPECIFC AIM 1: CHARACTERIZATION OF OAS1B MEDIATED DISEASE
FLAVIVIRUS DISEASE RESISTANCE IN MICE

INTRODUCTION
The genus Flavivirus in the family Flaviviridae, includes West Nile virus (WNV), dengue
virus, yellow fever virus (YFV) and Zika virus (ZIKV). These are mosquito-borne, zoonotic
pathogens that typically induce no symptoms or a mild febrile illness in infected humans but can
cause serious neurological pathology (Lindenbach, Murray et al. 2013). A genetically controlled
resistance phenotype that is specific for members of the genus Flavivirus was previously
discovered in mice. Resistance is conferred by a single, autosomal, dominant allele of the Flv locus
(Flvr) (Shellam, Sangster et al. 1998, Brinton and Perelygin 2003). Flvr mice are permissive to
infection by flaviviruses but produce lower virus titers and do not develop symptoms after
infection with doses of flavivirus that cause disease and death in animals that are homozygous for
the susceptible allele (Flvs). The Flv locus was subsequently identified as the Oas1b gene
(Perelygin, Scherbik et al. 2002). The mRNA for the susceptibility allele of the Oas1b gene
contains a premature stop codon and produces a truncated protein (Oas1bt) that lacks the Cterminal transmembrane domain. The C-terminal region of the Oas1b resistance allele was
knocked into the susceptible allele in C57BL/6 mice using a homologous recombination strategy
and a line of homozygous C57BL/6 Oas1b+/+ mice were then bred (Scherbik, Kluetzman et al.
2007). These mice are fully resistant to flavivirus-induced disease, confirming that expression of
the full length Oas1b protein is necessary for the resistance phenotype.
Oas1b is a member of the OAS gene family and OAS genes are interferon stimulated genes
(ISGs) (Kakuta, Shibata et al. 2002). The human genome encodes single copies of the OAS1,
OAS2, OAS3 and OASL genes. In contrast, the mouse genome contains single copies of Oas2 and
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Oas3, two copies of OasL, and eight copies of Oas1 (Oas1a-Oas1h). Only the mouse Oas1a and
Oas1g proteins have 2′, 5′-oligoadenylate synthetase enzymatic activity (Elbahesh, Jha et al. 2011,
Elkhateeb, Tag-El-Din-Hassan et al. 2016). OAS proteins are activated by dsRNA and therefore
detect virus infections in infected cells (Donovan, Dufner et al. 2013). Upon activation, OAS
proteins polymerize ATP and generate short 2′-5′ linked oligoadenylates that activate cytosolic
endoribonuclease RNase L. RNase L dimerizes and then non-specifically degrades single-stranded
RNAs, including viral RNAs (Silverman 2007). RNase L was previously shown to have antiviral
activity against flaviviruses. WNV genomic RNA is susceptible to cleavage by RNase L and
C57Bl/6RNase L-/- MEF cell lines had 5 to 10 times higher WNV yields compared to C57BL/6
cell lines (Scherbik, Paranjape et al. 2006). Samuel et al. (Samuel, Whitby et al. 2006) found that
only 10% of C57BL/6 mice lacking PKR and RNase L survived WNV infection compared to 70%
survival of WT C57BL/6 mice. Oas1b is an inactive synthetase and also has a dominant negative
effect on 2-5A production by an active Oas1 synthetase (Elbahesh, Jha et al. 2011).
The C-terminal domain of Oas1b targets it to the ER membrane in cells. Viral RNA
replication occurs within viral protein-induced invaginations within the ER membrane. The
localization of Oas1b to these invaginations could be related to its anti-flavivirus action. A yeast
two-hybrid screen identified two putative cellular Oas1b binding partners: ATP-binding cassette
3, subfamily f (ABCF3) and oxysterol binding protein-related protein 1L (Orp1L) (Courtney, Di
et al. 2012). ABCF3 interacted with both Oas1b and Oas1bt whereas Orp1L only interacted with
the full-length protein. The transmembrane domain of Oas1b was not necessary for the Orp1L
interaction. A knockdown of ABCF3 resulted in increased flavivirus specific replication in
resistant MEFs and overexpression of ABCF3 increased the flavivirus-specific inhibition of virus
replication in resistant MEFs. Knockdown of Orp1L in resistant MEFs caused decreased viral
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replication that was not specific to flaviviruses. Orp1L is a regulator of endosomes and it is likely
that the observed effect was on virus entry and due to dysregulation of the endosomal pathway
(Courtney, Di et al. 2012). The specific roles of these partners in the flavivirus-specific inhibition
mechanism mediated by Oas1b is not known.
To analyze the contribution of the antiviral activity of RNase L to the flavivirus resistance
phenotype in resistant mice, Oas1b+/+ mice were bred with RNase L-/- mice to generate
Oas1b+/+/RNase L-/- animals and flavivirus infection in these animals was characterized. Resistant
mice deficient for RNase L were fully resistant to flavivirus-induced disease and demonstrated
decreased viral yields and levels of viral genomic RNA compared to susceptible mice with and
without RNase L. Susceptible RNase L-/- mice demonstrated increased viral titers compared to
RNase L+/+ mice, confirming the anti-WNV activity of RNase L. Consistent with the lower viral
titers in resistant mice, the Type 1 IFN response was upregulated to a lower level in the resistant
mice compared to the susceptible mice.

MATERIALS AND METHODS
Generation of an Oas1b+/+/RNase L-/- mouse strain.
All animal work was done in accordance with approved IACUC protocols. Two C57BL/6 breeding
pairs were obtained from Jackson Labs and used to initiate a colony at Georgia State University.
C57BL/6 mice are homozygous for the susceptibility allele of the Oas1b gene (produce Oas1btr).
Previously, a new strain of flavivirus resistant mice C57BL/6 Oas1b+/+ was generated by knocking
in the resistant allele from C3H.PRI-Flvr mice into the C57BL/6 genome using a homologous
recombination strategy (Scherbik, Kluetzman et al. 2007). C57BL/6 mice which are homozygous
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for RNase L knockout (C57BL/6 RNase L-/-) were obtained from Dr. Robert Silverman (Cleveland
Clinic). C57BL/6 Oas1b+/+ mice were bred to C57BL/6 RNase L-/- mice. The F1 progeny were
then bred. The F2 progeny were genotyped for each allele of interest by southern blotting as
previously described (Scherbik, Kluetzman et al. 2007). Animals homozygous for both the
resistant Oas1b and RNase L-/- alleles were used as breeders to establish a colony of C57BL/6
Oas1b+/+/RNase L-/- mice.

Cells and viruses.
Baby hamster kidney 21/W12 (BHK) cells were maintained in minimal essential medium (MEM)
with 2.5% heat-inactivated fetal bovine serum (FBS) and 10 µg/ml gentamicin at 37˚C and 5%
CO2 (Courtney, Di et al. 2012).
YFV-17D lyophilized vaccine (Wyeth Laboratories) was reconstituted in sterile PBS according to
the manufacturer’s instructions. The virus titer was 4x106PFU/ml. An aliquot of WNV strain NY99
was obtained from Dr. Robert Tesh at the World Reference Center for Emerging Viruses and
Arboviruses, University of Texas Medical Branch. A virus stock was prepared by infecting
confluent BHK monolayers at a MOI of 0.1. The culture fluid was harvested at 42 hours post
infection (hpi), clarified by low speed centrifugation, aliquoted and stored at -80˚C. The titer of
this stock was 6.5x106PFU/ml. The infectivity of both YFV and WNV samples was determined
by plaque assay on BHK cells as previously described (Courtney, Di et al. 2012). Briefly, virus
was serially diluted in MEM supplemented with 2.5% FBS and adsorbed on confluent BHK
monolayers for 1 hr at 37˚C. After the incubation period, the virus inoculum was aspirated and the
cells were washed with Hank’s balanced salt solution (HBSS) and then overlaid with 2 ml/well of
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1% SeaChem (Bio-Whittaker Molecular Applications) agarose mixed 1:1 with 2X MEM
containing 5% fetal calf serum. The cells were incubated at 37˚C for 72 hpi then stained using
0.05% crystal violet in 10% ethanol. All samples were assayed in duplicate.

Mouse infection protocols.
Groups of 6 to 8 week old mice were anesthetized using 2% isoflurane until a surgical plane was
reached. The mice were then injected by the intracerebral (IC) route using a 26½ gauge needle
fitted with a plastic guard with 500 PFU of YFV-17D or with 100 PFU of NY99 in 0.01 ml of
sterile PBS.
For in vivo virus susceptibility experiments, following IC virus inoculation, mice were initially
observed once daily for the development of signs of encephalitis and then twice daily when signs
appeared. The posture, grooming behavior, and presence of limb paralysis were assessed to
determine disease severity. Animals demonstrating hindlimb paralysis were assessed to be
moribund, euthanized and counted as having died the next day.

Analysis of infectious virus, viral RNA and ISG mRNA levels in the brains of infected mice.
On different days following virus inoculation, groups of mice were sacrificed every day starting
on day two. Mice were deeply anesthetized with isoflurane. Once at a surgical plane, the mice
were decapitated and the brains aseptically removed. The brains were cut in half on the sagittal
plane using a sterile razor blade. Each half was weighed and stored at -80˚C. To make brain tissue
homogenate, one half was of each brain placed into a dounce homogenizer on ice and the correct
amount of ice cold DMEM containing 2.5% FCS to give a 10% W/V homogenate was added.
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After douncing 20 times, the homogenate was centrifuged at 2,000 x g at 4˚C. The supernatant was
collected and centrifuged at 10,000 x g at 4˚C. The clarified supernatant was aliquoted, stored
at -80˚C and used to determine virus infectivity by plaque assay on BHK cells. The other half of
each brain was stored in RNAlater stabilization solution (ThermoFisher Scientific) and used for
RNA analysis.
The brain halves stored in RNAlater solution were homogenized in dounce homogenizers that
contained the correct amount of TRI Reagent (Molecular Research Center) needed to give a 10%
W/V homogenate. Total RNA was extracted according to the manufacturer’s protocol. The
concentration and quality of the RNA were determined using a Nanodrop UV-VIS
spectrophotometer. The amount of viral RNA was quantified using a TaqMan one-step RT-PCR
master mix reagent kit (Applied Biosystems) according to the manufacturer’s protocol. Reactions
contained 300 µg of RNA. The primer and probe set targeted the WNV NY99 NS1 region
(SigmaAldrich). The primer sequences were: forward primer 5′-GGCAGTTCTGGGTGAAGT-3′;
reverse

primer

5′-GCTTTCCGCTCTCTGTGGTGG-3′;

TGTACGTGGCCTGAG-ACGCATACCTTGT-TAMRA-3′.

Taqman
WNV

probe

genomic

5′-6FAMRNA

was

normalized to cellular GAPDH in each sample and was quantified using a standard curve generated
from serially diluted WNV NY99 genomic RNA of a known concentration.
Real time quantitative reverse transcription-PCR (qRT-PCR) analysis of mouse ifnβ, oas1a and
oas1b mRNA in mouse brains was performed in a 10 µl reaction containing 500 ng of total RNA
as determined by NanoDrop, 1 µM of the target gene primer pair and 0.2 µM of the target gene
probe. Applied Biosystems Assays-on-Demand 20x primer and fluorogenic TaqMan FAM/MGB
probe mixes Mm00439552 for ifnβ, Mm00836412 for oas1a, and Mm0049297 for oas1b were
used for each mRNA tested. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was
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used as an endogenous control for each sample and was detected with TaqMAn mouse GAPDH
primers and probe (Applied Biosystems). One-step RT-PCR was performed for each target gene
and for the endogenous control using TaqMan RNA-to-Ct 1-Step Kit (Applied Biosystems). Each
sample for each target was tested in triplicate. The cycling parameters were as follows: reverse
transcription at 45°C for 15 min, TaqMan enzyme activation at 95°C for 10 min, denaturation at
95°C for 15 secs, annealing/extension at 60°C for 1 min (cycle repeated 40 times). Values for
target genes were normalized to GAPDH CT values and presented as fold change compared to
mock.

Immunofluorescence assay (IFA) of brain tissue.
On different days following virus inoculation, mice were deeply anesthetized with isoflurane and
then transcardially perfused first with ice cold PBS and then with 4% paraformaldehyde. The
brains were then removed and cut into 1 mm sections using a tissue slicer (Stoelting, Wood Dale,
IL) The sections were stored at 4˚C in 4% paraformaldehyde overnight and then transferred to
30% sucrose until the sections sank. They were then moved to PBS. Prior to additional sectioning,
the tissue was washed three times with PBS to remove any residual sucrose, embedded in O.C.T.
compound and was then sectioned to create sections between 10 and 20 µm in width. The tissues
sections were incubated at 4˚C with 5% normal horse serum (NHS) and 0.1% Triton-X overnight
and then incubated with primary antibodies diluted in 5% NHS/0.1% Triton-X solution overnight
at 4˚C. The antibodies used were mouse anti-dsRNA (English & Scienctific Consulting, Hungary,
1:1000) and chicken anti-NeuN (Millipore, 1:250). Following primary antibody incubation, the
sections were washed three times with PBS and incubated with donkey anti-mouse Alexa Fluor
594 and donkey anti chicken Alexa Fluor 488 conjugated secondary antibodies diluted in 5%
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NHS/0.1% Triton-X supplemented with Hoechst 33258 dye (DAPI) (Invitrogen) for one hour. The
sections were then washed in PBS and mounted on microscope slides with Prolong Gold anti-fade
reagent (Invitrogen). Images were obtained with a PerkinElmer UltraVIEW VoX spinning disc
confocal fluorescence microscope and were processed using Volocity software (PerkinElmer).

RESULTS
Resistant mice lacking RNase L survive lethal doses of WNV and YFV.
RNase L was previously shown to have anti-WNV activity (Scherbik, Paranjape et al.
2006). To determine whether the RNase L antiviral activity contributes to the Oas1b-mediated
resistance phenotype in vivo, a strain of resistant mice lacking RNase L were generated. C57BL/6
RNase L -/- mice (Zhou, Paranjape et al. 1997) were bred to flavivirus resistant C57BL/6 Oas1b+/+
mice (Scherbik, Kluetzman et al. 2007). The F1 progeny were then mated and the F2 mice were
genotyped. Mice homozygous for both the resistance Oas1b allele and for the RNase L knockout
allele were selected and used to establish a strain of C57BL/6 Oas1b+/+/RNase L-/- mice.
Groups of 6 to 8 week old mice of each of two C57BL/6 mouse strains homozygous for
the susceptibility allele (Oas1btr), C57BL/6 WT and C57BL/6 RNase L-/-, and of each of two
strains homozygous for the resistance allele (Oas1b), C57BL/6 Oas1b+/+ and C57BL/6
Oas1b+/+/RNase L-/-, were inoculated by the IC route with either 500 PFU of YFV-17D or 100
PFU of WNV NY99 and monitored for 25 days for signs of encephalitis. All of the C57BL/6 and
C57BL/6 RNase L-/- mice inoculated with YFV-17D became moribund and were euthanized
between 10 and 20 days after infection (Figure 2.1A). Mice of the same two strains inoculated
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Figure 2.1 Survival curves for mice infected intracranially with a flavivirus. A) Survival
curves for 6 to 8 week old C57BL/6 mice (n=14), C57BL/6 RNase L-/- mice (n=10), C57BL/6
Oas1b+/+ mice (n=15) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=15) infected with 500 PFU of
YFV-17D vaccine. B) Survival curve of 6 to 8 week old C57BL/6 mice (n=11), C57BL/6 RNase
L-/- mice (n=13), C57BL/6 Oas1b+/+ mice (n=11) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=14)
infected with 100 PFU of WNV NY99. Both viruses were diluted in sterile PBS and were
intracranially injected with a volume of 10 µL.
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with WNV NY99 became moribund and were euthanized between 5 and 11 days after infection
(Figure 2.1B). In contrast, none of the C57BL/6 Oas1b+/+ or C57BL/6 Oas1b+/+/RNase L-/- mice
infected with either virus displayed any detectable disease symptoms during the observation
period. The data indicate that RNase L is not required for Oas1b-mediated resistance to flavivirusinduced disease in mice.

WNV production in the brains of resistant mice that express or lack RNase L.
Flavivirus yields are lower in the brains of flavivirus resistant mice than in susceptible mice
(Brinton, Arnheiter et al. 1982, Urosevic, van Maanen et al. 1997). Although the lack of RNase L
did not negatively affect the survival time of Oas1b+/+/RNase L-/- mice after a flavivirus infection,
it was possible that the lack of RNase L increased virus yields in resistant mouse brains. To test
this possibility, groups of 6 to 8 week old C57BL/6, C57BL/6 RNase L-/-, C57BL/6 Oas1b+/+, and
C57BL/6 Oas1b+/+/RNase L-/- mice were infected intracranially with 100 PFU of WNV and virus
titers in brains homogenates were determined on days 2 through 8 post infection (dpi) by plaque
assay (Figure 2.2). At 2 dpi, the levels of infectious virus in the brains was low (2-2.5 log) for all
four strains of mice. At 3 dpi, the virus titers in the brains of the C57BL/6 RNase L-/- mice had
increased by ~100-fold compared to the brains of C57BL/6 while the titers for the other three
strains was comparable to the levels at 2 dpi. At 4 dpi, the C57BL/6 and C57BL/6 RNase L-/- virus
titers had increased by approximately 1200-fold and 2800-fold, respectively, while the titers in the
brains of the two resistant strains had only increased by 3-fold. Peak virus yields were observed
for all four of the mouse strains at 5 dpi and were: 106.8 PFU/g in the C57BL/6 RNase L-/- brains,
106 PFU/g in the C57BL/6 brains, 103.2 PFU/g in the C57BL/6 Oas1b+/+ brains and 103 PFU/g in
the C57BL/6 Oas1b+/+/RNase L-/- brains. The virus titers in the brains of the two resistant strains
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Figure 2.2. Infectious virus yields in brains of flavivirus resistant and flavivirus susceptible
mice infected with WNV. Six to eight week old C57BL/6 mice (n=24), C57BL/6 RNase L-/- mice
(n=21), C57BL/6 Oas1b+/+ mice (n=25) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=28) were
infected intracranially with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL.
Infectious titers in brain tissue homogenates were determined by plaque assay on BHK cells. Each
time point represents at least three animals. Data points represent mean value and error bars are
S.E.M. *p<0.05; Mann-Whitney
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decreased to undetectable levels by 8 dpi. These data show that C57BL/6 RNase L-/- mice produced
increased virus yields compared to C57BL/6 but similar low titers were produced by resistant mice
with and without RNase L.

Comparison of the levels of WNV genome RNA in the brains of resistant mice that express
or lack RNase L.
RNase L was previously shown to be able to cleave WNV genome RNA (Scherbik,
Paranjape et al. 2006). To determine if RNase L played a role in decreasing viral genomic RNA
levels, groups of 5 to 6 adult (6 to 8 weeks) C57BL/6, C57BL/6 RNase L-/- C57BL/6 Oas1b+/+,
and C57BL/6 Oas1b+/+/RNase L-/- mice were infected with 100 PFU of WNV and their brains were
harvested on various days post infection. Total RNA was extracted and the level of viral genomic
RNA was determined by qRT-PCR (Figure 2.3). Similar low levels of virus RNA were detected
in the brains of the C57BL/6, C57BL/6 Oas1b+/+, and C57BL/6 Oas1b+/+/RNase L-/- mice tested at
2 dpi. However, the viral RNA levels were significantly higher at 1 dpi in the brains of the
C57BL/6 RNase L-/- mice (Figure 2.3). By 4 dpi, viral RNA levels had increased dramatically in
the susceptible C57BL/6 and C57BL/6 RNase L-/- brains but had increased only slightly in the
resistant C57BL/6 Oas1b+/+ and C57BL/6 Oas1b+/+/RNase L-/- brains (Figure 2.3). The viral RNA
levels further increased in the susceptible C57BL/6 mice on days 5 and 6. The viral RNA levels in
the resistant C57BL/6 Oas1b+/+ and C57BL/6 Oas1b+/+/RNase L-/- increased only slightly on days
4 and 5 and decreased on day 6. The data indicate that the presence of RNase L reduces the levels
of viral RNA at early time (2 dpi) after infection.
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Figure 2.3. RNA production in the brains of susceptible and resistant mice infected with
WNV. Six to eight week old C57BL/6 mice (n=24), C57BL/6 RNase L-/- mice (n=21), C57BL/6
Oas1b+/+ mice (n=25) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=28) were infected intracranially
with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL. Brains were aseptically
removed and total RNA was extracted using phenol-chloroform extraction. Viral RNA was
quantified by qRT-PCR and the RNA copy number was determined by comparison to a standard
curve generated with serially diluted NY99 genomic RNA of a known concentration. The level of
viral RNA in each sample was normalized to GAPDH in that sample. Each data point represents
RNA measurement from a single mouse brain. Horizontal bars represent the means. *p<0.05,
****p<0.001; Unpaired student’s t-test.
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Analysis of the Type 1 interferon response in the brains of resistant mice that express or lack
RNase L
The induction of the Type 1 IFN pathway by WNV was analyzed in the brains of infected
C57BL/6, C57BL/6 RNase L-/-, C57BL/6 Oas1b+/+, and C57BL/6 Oas1b+/+/RNase L-/- mice. Total
RNA extracted from these brains and from mock infected animals was analyzed by qRT-PCR for
ifnβ, oas1a and oas1b mRNA levels (Figure 2.4). At 2 dpi the ifnβ mRNA levels were 10-fold
higher than the levels in mock infected brains for all four mouse strains. At 4 dpi and 6 dpi, the
level of ifnβ mRNA was 1000-fold higher in C57BL/6 and C57BL/6 RNase L-/- mouse brains but
only 10-fold higher in C57BL/6 Oas1b+/+ or in C57BL/6 Oas1b+/+/RNase L-/- compared to the level
in mock brains (Figure 2.4A). The lower level of ifnβ mRNA expression in the brains of the
resistant mice compared to the susceptible mice is consistent with the lower level of virus
production in those brains.
Oas1a mRNA levels were 10-fold higher in C57BL/6 RNase L-/- and C57BL/6
Oas1b+/+/RNase L-/- at 2 dpi compared to the levels in mock infected brains whereas the levels in
C57BL/6 was 5-fold higher and in C57BL/6 Oas1b+/+ were 2-fold higher (Figure 2.4B). At both 4
dpi and 6 dpi the levels of oas1a mRNA was 10-fold higher in C57BL/6 brains and ~100-fold
higher in C57BL/6 RNase L-/- and C57BL/6 Oas1b+/+/RNase L-/- brains compared to mock infected
brains (Figure 2.4B). The levels of oas1a mRNA in C57BL/6 Oas1b+/+ brains were ~2-fold higher
at 4 dpi and ~10-fold higher at 6 dpi (Figure 2.4B).
The level of oas1b mRNA was <10-fold higher compared to mock infected brains at each
day tested in C57BL/6 mice and was 10-fold higher in C57BL/6 RNase L-/- mice at 2dpi and then
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Figure 2.4. Upregulation of IFN and Oas1 mRNA expression in the brains of susceptible and resistant
mice infected with WNV. Six to eight week old C57BL/6 mice (n=6), C57BL/6 RNase L-/- mice (n=6),
C57BL/6 Oas1b+/+ mice (n=6) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=6) were infected intracranially
with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL. Brains were aseptically removed
and total RNA was extracted with phenol:chloroform. Brain RNA was analyzed for the levels of A) infβ,
B) oas1a or C) oas1b mRNA using qRT-PCR. CT values were normalized to GAPDH in each sample fold
change is relative to the levels in the brains of mock infected animals of each strain. Each data point
represents a single mouse brain. Horizontal bars represent the means.
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50-fold higher at 4 dpi and 6 dpi (Figure 2.4C). The average level of oas1b mRNA in the brains
of the C57BL/6 Oas1b+/+ mice was ~50-fold higher at all times tested although at 6 dpi the level
had dropped 10-fold in two of the mice tested (Figure 2.4C). The oas1b mRNA level in the
C57BL/6 Oas1b+/+/RNase L-/- was 50-fold higher at 2 dpi but was more than 100-fold higher at 4
dpi and 6 dpi (Figure 2.4C).

Analysis of flavivirus RNA replication in mouse brain cells by IFA.
The intensity of the IFA signal for antibody to dsRNA indicates the level of viral RNA
replication that is occurring in an infected cell. The kinetics of WNV RNA replication in cells in
the brains of infected mice were investigated. Viral RNA replication complexes in infected cells
in the brains of resistant C57BL/6 Oas1b+/+ mice and susceptible C57BL/6 mice were detected
with anti-dsRNA antibody and neurons were detected with anti-NeuN antibody. On different days
following intracranial inoculation with 500 PFU of YFV-17D or with 100 PFU of WNV NY99,
mice were perfused with 4% paraformaldehyde and the brains processed for immunofluorescence
using anti-dsRNA antibody and anti-NeuN antibody (Figure 2.5 & 2.6). At early times after
infection (2 days for WNY NY99 and 4 days for YFV) the majority of NeuN-positive cells in
fields of brain sections analyzed from both C57BL/6 and B57BL/5 Oas1b+/+ mice infected with
either virus were positive for dsRNA (Figure 2.5 & 2.6). In neurons from both resistant and
susceptible mice, the dsRNA signal was a thin perinuclear ring of similar signal intensity (Figure
2.5 & 2.6). At later times after infection (4 dpi for WNB NY99 and 9 dpi for YFV), the intensity
and area of the dsRNA signal had increased in the brains of the susceptible mice but neither the
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Figure 2.5. Level of dsRNA staining in the brains of resistant and susceptible mice following
infection with WNV NY99. Six to eight week old C57BL/6 mice or C57BL/6 Oas1b+/+ were
infected intracranially with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL.
At different days post infection, mice perfused with 4% PFA and the brains were sectioned and
processed for IFA using anti-NeuN antibody (green) for neurons and anti-dsRNA antibody (red)
for infected cells. Dapi (blue) was used to stain nuclei. Scale bars = 18 µm. Enlarged panel scale
bars = 9 µm.
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Figure 2.6. Level of dsRNA staining in the brains of resistant and susceptible mice following
infection with YFV-17D. Six to eight week old C57BL/6 mice or C57BL/6 Oas1b+/+ were infected
intracranially with 500 PFU of YFV-17D diluted in sterile PBS in a volume of 10 µL. At different
days post infection, mice perfused with 4% PFA and the brains were sectioned and processed for
IFA using anti-NeuN antibody (green) for neurons and anti-dsRNA antibody (red) for infected
cells. Dapi (blue) was used to stain nuclei. Scale bars = 22 µm. Enlarged panel scale bars = 7 µm.
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size nor intensity of the signal increased in the brains of the resistant mice (Figure 2.5 & 2.6).
These data are consistent with the lower levels of viral genome RNA detected in resistant brains
and indicate that the amplification of genome RNA replication in resistant mouse brains is
inhibited at later times after infection.

DISCUSSION
In response to invading RNA viruses, OAS proteins synthesize 2-5A to activate the
endoribonuclease RNase L that non-specifically degrades RNAs in the cytoplasm. One murine
OAS protein, Oas1b, is an inactive synthetase that confers resistance to flavivirus disease to mice
through a mechanism that does not utilize 2-5A production (Elbahesh, Jha et al. 2011). However,
mice encode other OAS proteins that are active synthetases and RNase L activation was previously
shown to have anti-WNV activity (Scherbik, Paranjape et al. 2006, Elkhateeb, Tag-El-Din-Hassan
et al. 2016). To determine the contribution of the anti-flavivirus activity of RNase L to flavivirus
disease resistance, mice that were RNase L-/- were bred with resistant Oas1b+/+ mice and their
response to infection with flavivirus was analyzed. Oas1b+/+/RNase L-/- mice had the same
infection survival outcome and viral replication kinetics as resistant mice with RNase L. These
results indicate that RNase L activation is not necessary for the full expression of the Oas1bmediated flavivirus disease resistance phenotype in mice.
The OAS/RNase L pathway was one of the first IFN-dependent antiviral pathways to be
characterized, and has been shown to have antiviral activity against several RNA viruses including
WNV (Scherbik, Paranjape et al. 2006). Replicative intermediate dsRNAs produced by viruses
during replication are detected by the OAS proteins which synthesize 2-5A oligomers to activate
RNase L. Secondary structures in viral genomes can also be detected by the OASs (Elbahesh, Jha
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et al. 2011, Deo, Patel et al. 2015). Flaviviruses such as WNV sequester their dsRNA in replication
vesicles composed of ER membrane invaginations that provide protection from detection and
degradation by the OAS/RNase L pathway. These vesicles are detected by 8-10 hpi. Prior to the
formation of these vesicles viral RNA is membrane associated but partially exposed and can
activate the OAS pathway, leading to early RNA degradation (Welsch, Miller et al. 2009). In the
current study C57BL/6 RNase L-/- mice had 10-fold higher levels of WNV genome RNA at 2 dpi
(Figure 2.3), which likely contributed to the increased levels of virus production observed at 3 dpi
compared to C57BL/6 mice (Figure 2.2). At 4 dpi and onward, the levels of WNV genome RNA
were comparable between these two mouse strains, indicating that RNase L activity was no longer
efficiently reducing genome RNA production. This timing coincided with the amplification of the
dsRNA signal in neurons by 4 dpi, suggesting that the formation of replication vesicles had
occurred and that exponential genome RNA production was taking place in the protective
environment of these vesicles (Figure 2.5). There is no evidence that any WNV proteins can
directly inhibit the activity of an OAS protein or of RNase L and sequestering of the replicating
viral RNA is a critical component of WNV immune evasion strategy during infection in host cells.
Despite Oas1b being an ISG and despite the important role of Type 1 IFNs in controlling
virus replication in cells, Type 1 IFN activity appears to be dispensable for the anti-flavivirus
response in resistant mice (Brinton, Arnheiter et al. 1982). Comparison of the Type 1 IFN response
in the brains of resistant and susceptible mice indicated that at 2 dpi, higher ifnβ mRNA levels
were detected for all four animal strains tested compared to mock infected animals suggesting
efficient activation of the IFN pathway (Figure 2.4A). At 4 and 6 dpi, there was no additional rise
in ifnβ mRNA levels in resistant animals whereas the levels in susceptible rose by 100-fold. This
increase in the ifnβ mRNA levels in susceptible mouse brains was accompanied by a rise in oas1a
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mRNA levels but not in oas1b mRNA levels (Figure 2.4B, C). The higher level of oas1a mRNA
detected in the brains of the two RNase L-/- strains is likely due to the lack of cell mRNA
degradation by activated RNase L. The low levels of oas1b mRNA in susceptible C57BL/6 cells
is likely due to a high turnover of the oas1b mRNA due to the presence of a premature stop codon.
Flavivirus genome RNA production in resistant mice and MEFs is exponentially lower
compared to that in susceptible mice (Urosevic, van Maanen et al. 1997, Scherbik, Paranjape et al.
2006). However, the levels of replicative intermediate RNAs were comparable between resistant
and susceptible mice at early days following infection as detected by Northern blotting, providing
additional evidence that the Oas1b-mediated inhibition of viral infection occurs at the level of plus
strand RNA production (Urosevic, van Maanen et al. 1997). To directly observe the kinetics of
viral RNA replication in neurons in vivo, infected resistant and susceptible mouse brains were
stained with anti-dsRNA antibody. At later times in infection with either YFV or WNV the
intensity of the dsRNA signal increased in susceptible mice but did not change in intensity in
resistant mice. The size of the dsRNA signal area also increased in the susceptible mice suggesting
an expansion of the replication vesicles, either in size or in number, inside the ER of the infected
neurons. Neither the size nor the intensity of the dsRNA signal area increased with time in the
infected neurons of the resistant mice. Inhibition of either the formation of new replication vesicles
and/or of the mechanism mediating exponential genome replication inside the replication vesicles
could be due to targeting of the full length Oas1b complex to the ER membrane via the Oas1b
transmembrane domain. However, the mechanism by which Oas1b inhibits viral RNA synthesis
is not yet known.
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SPECIFIC AIM 2: CHARACTERIZATION OF THE RESPONSE OF HUMAN
PLURIPOTENT STEM CELL-DERIVED CNS CELLS TO INFECTION WITH
AVIRULENT AND VIRULENT STRAINS OF WNV

INTRODUCTION
Viruses of the genus Flavivirus are arthropod-borne zoonotic pathogens that normally
cause mild febrile illness but can also cause serious pathology including encephalitis, acute flaccid
myelitis, hemorrhagic fever and microcephaly in children born to infected mothers. Mosquitoborne flaviviruses that are known to cause severe disease in humans include West Nile virus
(WNV), Dengue virus (DENV) and Zika virus (ZIKV) (Lindenbach, Murray et al. 2013).
Flavivirus genomes are ~11,000 nt, single-stranded, positive sense RNA [(+)RNA] with a 5′-cap
but no 3′-poly(A) tail . The genome serves as the viral mRNA with a single open reading frame
(ORF) encoding three structural (capsid, envelope and prM) and seven non-structural proteins
(NS1, NS2A, NS2B NS3, NS4A, NS4B, NS5). All of the non-structural proteins are involved in
replicating the viral RNA and some are involved in evading the host cell immune response (Brinton
2014).
Most WNV strains are classified into two distinct clades: lineage I and lineage II. Lineage
I viruses are found throughout the world and are associated with outbreaks of CNS disease.
Neurovirulent NY99 is a lineage I virus (Beasley, Li et al. 2002, Keller, Fredericksen et al. 2006).
Lineage II viruses are endemic to Africa and have recently emerged in southern Europe (Zehender,
Veo et al. 2017). Although both lineages include WNV strains that are neurovirulent and cause
CNS disease and death following IC inoculation in mice, the lineage II strain MAD78 is not
neurovirulent (Beasley, Li et al. 2002).
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In mice, pathogenic strains of WNV directly infects neurons in the basal ganglia, thalamus,
midbrain, cerebellum and spinal cord (Shives, Tyler et al. 2017). Subsets of mouse primary
neurons demonstrate varying sensitivity to infection by different strains of WNV due to differences
in baseline expression of host defense genes and ISGs (Cho, Proll et al. 2013). WNV infection of
mice astrocytes and microglial cells has also been observed (Quick, Leser et al. 2014). Histological
analysis of CNS tissue from humans that succumbed to WNV encephalitis showed infected
neurons in the brainstem, spinal cord, cerebellum, hippocampus and thalamus (Armah, Wang et
al. 2007). Human primary neurons and astrocytes are permissive to infection by WNV although
the efficiency of infection for some of these cell types varies with the WNV strain (Samuel, Whitby
et al. 2006, Hussmann, Samuel et al. 2013, Quick, Leser et al. 2014).
Neural progenitor cells (NPCs) are found in the brain in the subventricular zone (SVZ) and
the hippocampal dentate gyrus (DG) (Bond, Ming et al. 2015). During normal embryonic CNS
development, NPCs differentiate into radial glial cells which then give rise either to astrocytes,
microglial cells or neurons (Gotz and Huttner 2005). In adults, NPCs primarily respond to
environmental cues with a diverse range of functions including neurogenesis, memory formation
and response and repair to CNS injury (Garber, Vasek et al. 2018). Studies have shown that NPCs
are permissive to infection by Zika virus (ZIKV) and Japanese encephalitis virus (JEV) and
infection of NPCs by these viruses can inhibit cell proliferation and cause apoptosis (Tang,
Hammack et al. 2016, Mukherjee, Singh et al. 2017). It is not currently known if any strains of
WNV can infect NPCs in humans.
There are several factors that contribute to the development of CNS disease following
infection with WNV. The Type I IFN response is a critical component of survival following WNV
infection in mice. Type 1 IFN receptor-knockout mice infected with WNV have higher levels of

37

virus replication and succumb to infection faster than wild-type mice (Samuel and Diamond 2005).
The ability of viruses to antagonize Type 1 IFN signaling is a determining factor for
neurovirulence. Type 1 IFN knockout mice succumb to intracranial infection with nonpathogenic
MAD78 whereas mice with intact Type 1 IFN signaling do not (Keller, Fredericksen et al. 2006).
Inflammation in the CNS in response to WNV infection contributes to neuronal injury and disease
progression. Mouse brains infected with WNV show increased expression of pro-inflammatory
cytokines such as CXCL10, IL-6, CCL5 and TNF-α that facilitate trafficking of CD4+ and CD8+
T cells, natural killer cells and macrophages into the CNS (Samuel and Diamond 2009, Hussmann,
Samuel et al. 2013, Clarke, Leser et al. 2014, Quick, Leser et al. 2014). These proteins are also
secreted by human primary neurons and astrocytes in response to infection by WNV (Cheeran, Hu
et al. 2005) Replication of WNV and other flaviviruses in CNS cells can lead to induction of
caspase-3 and caspase-8-dependent apoptosis (Samuel, Morrey et al. 2007, Clarke, Leser et al.
2014, Tang, Hammack et al. 2016).
The majority of studies on WNV-mediated CNS disease have been in mice or in postmortem tissue. The limited availability of human post-mortem tissue and of donor-to-donor cell
variation present logistical problems for the use of this model. Mouse models are widely available
and the use of inbred strains decreases genetic variation. However, findings in mice are not always
directly applicable to humans. The use of human induced pluripotent stem cells (hiPSCs) to
produce a wide variety of cells for study circumvents many of the issues of the traditional models.
For this study, hiPSCs were differentiated into different types of neural cells that were used to
study WNV infection. WNV neurovirulent NY99 and non-neurovirulent MAD78 were used to
infect pure cultures of human NPCs, astrocytes, pre-mitotic neurons (PMN) or post-mitotic
neurons (MN). The infections were characterized using traditional virology methods along with
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Next Generation Sequencing (NGS) analysis of gene expression using global transcriptome
analysis (RNA-seq).

MATERIALS AND METHODS
Cells and viruses
Human iPSC lines were generated and maintained as previously described (Wen, Nguyen et al.
2014). The differentiation of hiPSC into forebrain-specific NPCs was performed as previously
described (Tang, Hammack et al. 2016). For all experiments with hiPSC-derived cells, the cells
were seeded into wells coated with Matrigel (Corning). Briefly, 6-well plates, 12 well plates or 24well plates that contained coverslips were coated with ice cold Matrigel diluted 1:60 in DMEM/F12 (Gibco) for at least 2 hours at 37°C. Cultures of NPCs were dissociated with Accutase
(ThermoFisher) at 37°C for 10 minutes. The cells were diluted with NPC media consisting of
DMEM/F12 supplemented with B27 (ThermoFisher), N2 supplement, NEAA, 2 μg/ml of heparin
(Sigma) and 2 μM cyclopamine (Tocris). ROCK inhibitor Y-27632 (5 µM) was added to the media
prior to seeding the cells. For differentiation of NPCs into neurons, dissociated NPCs were diluted
with Neurobasal medium (ThermoFisher) supplemented with B27, 2 mM Glutatmax (Gibco), 10
ng/ml BDNF (PeprotTech), 10 ng/ml GDNF (PeproTech), 1 µM cAMP (SigmaAldrich), and 200
ng/ml L-alanine and were seeded at a density of 5.6x104 cells/cm2. Astrocytes were maintained in
Astrocyte Medium (ScienceCell Research Laboratories).
Aliquots of WNV strain NY99 and WNV strain MAD78 were obtained from Dr. Robert Tesh
(World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical
Branch). Virus stocks were prepared by infecting confluent Vero monolayers at a MOI of 0.1. The
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culture fluid was harvested at 36 hours post infection hpi, clarified by low speed centrifugation,
aliquoted and stored at -80˚C. The titer of the WNV NY99 stock was 3.8x107 PFU/ml and the titer
of the WNV MAD78 stock was 3.3x107 PFU/ml.

Infection protocol
Monolayers of NPCs, astrocytes, and neurons were infected at 37°C/5% CO2 for 1 hour with
intermittent rocking. Briefly, culture media was aspirated and then virus diluted in cell media to
the appropriate MOI was added to the cells. The media was brought to room temperature prior to
adding virus to prevent the Matrigel coating from dissolving. After infection, the virus inoculum
was removed and the cells were washed with HBSS and fresh media was replaced.
The infectivity of WNV NY99 and WNV MAD78 samples was determined by plaque assay on
BHK cells as previously described (Courtney, Di et al. 2012). Briefly, virus was serially diluted in
MEM supplemented with 2.5% FBS and adsorbed on confluent BHK monolayers for 1 hour at
37˚C. After the incubation period, the virus inoculum was aspirated and the monolayers were
washed with HBSS and then overlaid with 2 ml/well of 1% SeaChem agarose (Bio-Whittaker
Molecular Applications) mixed 1:1 with 2X MEM containing 5% fetal calf serum. The cells were
incubated at 37˚C for 72 hpi and then stained using 0.05% crystal violet in 10% ethanol. All
samples were assayed in duplicate.

Drug treatment
Cells were seeded on Matrigel coated 12 well plates. Monolayers were infected with WNV NY99
(MOI=0.5). After the 1 hour adsorption period, the appropriate cell specific media with 1, 3, or 9
µM PHA-690509 or 0.1, 0.3 or 0.9 µM Niclosamide diluted in 1 % DMSO was added to the wells.
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Immunofluorescence Assay
Matrigel coated coverslips in 24-well plates were seeded with NPCs or astrocytes. NPCs were
maintained in NPC media or in neural induction media to produce neurons. Cells were infected
with WNV NY99 or WNV MAD78 (MOI=2) or mock infected. At different times post infection,
the media was aspirated and the cells were fixed with room temperature 4% paraformaldehyde for
10 min. The cells were washed once with room temperature PBS and then incubated with 0.1%
Triton-X for 10 minutes. The cells were then blocked in 5% NHS diluted in PBS for one hour at
room temperature. Primary antibodies were diluted in 5% NHS and the cells were incubated
overnight at 4 ˚C. The cells were washed three times with PBS then were incubated with secondary
antibodies diluted in 5% NHS containing 0.05% DAPI. The cells were washed three times with
PBS, then were mounted on microscope slides with ProLong Gold (ThermoFisher). Cells were
observed with a Zeiss Axio Observer Z1 inverted fluorescence microscope and images were
analyzed with Volocity software (PerkinElmer). The antibodies used were mouse J2 anti-dsRNA
(Scicons, 1:1000), goat anti-WNV NS3 (R & D Systems, 1:500), mouse anti-Nestin (Millipore,
1:500), mouse anti-MAP2 (Millipore, 1:500), mouse anti-CTIP2 (Millipore, 1:500), rabbit antiGFAP (Dako, 1:500), rabbit anti-cleaved Caspase 3 (Cell Signaling, 1:500), and mouse anti-Ki67
(Abcam, 1:500).

Western Blotting
Western blotting was done as previously described (Courtney, Di et al. 2012). Briefly, cell lysates
were harvested in RIPA buffer containing protease inhibitor cocktail (Roche). Proteins were
separated by SDS-PAGE and then transferred to nitrocellulose membrane. The membranes were
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blocked with 5% milk in tris-buffered saline (TBS) with 0.1% Tween-20 (TBS-T) for 1 hour.
Primary antibodies were diluted in blocking buffer and the membrane was incubated overnight at
4 ˚C. The membranes were washed three times with TBS-T then incubated with secondary
antibody in blocking buffer for one hour. Membranes were washed twice with TBS-T then once
with TBS. Membranes were incubated in Super-Signal West Pico chemiluminescent substrate
(ThermoFisher) and bands were detected using Las4000 mini Chemilumescent imager. The
primary antibodies used were goat anti-WNV NS3 (R & D Systems, 1:1000) and mouse anti-βactin (Cell Signaling, 1:10,000).

Cellular RNA extraction
Triplicate monolayers of astrocytes in Matrigel-coated 6-well plates were infected with WNV
NY99 at an MOI=0.5 or mock infected. Time points were taken at 24 and 48 hpi. Triplicate
monolayers of NPCs or astrocytes in Matrigel-coated 6-well plates were infected with WNV
MAD78 or WNV NY99 at an MOI=2 or mock infected. Time points were taken 12 and 24 hpi.
Replicate cell cultures for both cell types were grown in 24 well plates Matrigel-coated coverslips
and were also infected and used to determine the infection efficiency by IFA. For harvesting RNA,
culture fluid was removed and cell lysates were harvested in 1 ml Tri-reagent (Molecular Research
Center, inc). Total cellular RNA was extracted according to the manufacturer’s protocol. The RNA
was quantified using Qubit RNA Broad Range Assay kit and stored at -80 ˚C (ThermoFisher).
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RNA-seq and Transcriptome Analysis
The library preparation and RNA-sequencing (RNA-seq) was performed by Novogene. Briefly,
the mRNA poly(A) selected. RNA-seq libraries were generated from 1 μg of total RNA. RNA
from triplicate samples of either mock infected or infected cells at different time points after
infection were analyzed. The mRNA was fragmented randomly by adding fragmentation buffer,
then cDNA was synthesized by using mRNA template and random hexamers primer. A custom
second-strand synthesis buffer (Illumina), dNTPs, RNase H and DNA polymerase I were then
added to initiate second-strand synthesis. After sequencing adaptor ligation, the double-stranded
cDNA library was completed by size selection and Q-PCR enrichment using an Agilent 2100
BioAnalyzer and a DNA1000 kit (Agilent). Illumina paired-end (PE) MiSeq (20 million
reads/sample) sequencing was performed.
Alignment, mapping, and differential expression (DE) analysis was performed in the Linux
Operating System. Alignment of reads was carried out using Bowtie v.1.2.2 PE. RNA-seq reads
were aligned to the human transcriptome annotation assembly (hg38) using Tophat v.2.1.1.
Differential expressed gene (DEG) analysis was done using Cufflinks v.2.1.1. DEG data was
analyzed using CummerBund v.2.7.2 in an R environment v.3.4. Gene ontology (GO) analysis for
cellular pathways, biological processes, molecular function, and keywords were performed using
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8 (Huang da,
Sherman et al. 2009). Significantly enriched terms with a Benjamini-Hochberg score ≥0.05 were
not used. Protein-protein interaction network analyses were performed by using GeneMania
(Warde-Farley, Donaldson et al. 2010).
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Cell counting
Cultures of NPCs or SNB-19 cells were seeded in 6 well plates with or without Matrigel coating,
respectively. Twenty-four hours after seeding, cell cycles were synchronized by treatment with
2mM thymidine for 16 hours. After 16 hours, the cells were washed and fresh media was added.
Cell counts were determined prior to adding virus. The cells were infected with WNV NY99 at a
MOI=2. At 24 and 48 hpi, cell supernatants were harvested and centrifuged to pellet any cells that
had detached during infection. Cell cultures were trypsinized and these cells were added to the
tubes with the cell pellets. Cells were counted on a hemocytometer. Duplicate samples were
counted at each time point.

BrdU pulse-chase
Cultures of SNB-19 cells were seeded into 6 well plates. When the cells were 50% confluent, they
were infected with WNV NY99 at a MOI=2 or mock infected. After the incubation period, the
virus inoculum was aspirated and media was added that contained 2 mM thymidine. Sixteen hours
later, the thymidine media was removed and fresh media was added to the cells. For the BrdU
pulse-chase, 100 mM BrdU was added to the wells without removing the media and the cell
cultures were incubated for 30 minutes at 37˚C in the dark in a CO2 incubator. The cell media was
then aspirated and the cells were washed twice with ice-cold PBS. The cells were then trypsinized
and harvested. The cells were centrifuged at 500g for 5 minutes. The media was aspirated, and the
cells were resuspended in 250 µl of ice-cold PBS. Ice cold 100% ethanol was added dropwise to a
final volume of 1000 µl. The cells were stored at -20˚C until flow analysis.
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Quantification of secreted pro-inflammatory cytokines
Triplicate cultures of astrocytes were seeded in Matrigel coated 6 well plates and infected with
WNV NY99 or WNV MAD78 (MOI=2) or mock infected. Astrocyte cultures grown on Matrigel
coated coverslips in 24-well plates were also infected and analyzed by IFA to confirm infection
and determine infection efficiency. Culture fluids from astrocytes infected with WNV MAD78 or
WNV NY99 were collected at different times post infection. Pro-inflammatory cytokines CCL5,
CXCL10 and IL-6 were quantified with enzyme-linked immunosorbent assay (ELISA) kits (R &
D Systems) according to the manufacturer’s instructions.

RESULTS
WNV strain NY99 can efficiently infect four types of hiPSC-derived CNS cells
CNS cell types in mice previously shown to be permissive to WNV infection are neurons,
microglial cells and astrocytes (Winkelmann, Luo et al. 2016). To determine which human iPSCderived CNS were permissive to WNV infection, pure cultures of NPCs, astrocytes, PMN and MN
in Matri-gel coated plates from two different donor sources of hiPSCs were infected with WNV
NY99 (MOI=0.5). The virus growth kinetics were determined by measuring the virus titer in the
supernatant by plaque assay (Figure 3.1A). All four cell types from both donors replicated virus
efficiently (Figure 3.1A). The MN cultures from both donors showed a higher amount of residual
virus in the media following infection as indicated by the viral titers at 0 hpi, suggesting the
possibility of less efficient viral entry compared to the other cell types. To assess the infection
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Figure 3.1. NY99 infection in four hiPSC-derived CNS cell types. Cultures of iPSC-derived
NPCs, astrocytes, PMN or MN were infected with NY99 (MOI=0.5). A) Supernatants were
harvested at the indicated times and the infectious viral titer was determined by plaque assay on
BHK cells. B-D) Infected coverslips were fixed with 4% paraformaldehyde at 48 hpi and processed
for IFA with anti-WNV NS3 antibody and B) anti-nestin, C) anti-MAP2 or D) anti-CTIP2. DAPI
was using to stain nuclei. E) Quantification of number of infected cells in cultures of each cell
type. Each data point represents the average from three replicate experiments. Error bars are
standard error of the mean.
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rate, infected cells on Matri-gel coated coverslips were fixed with 4% paraformaldehyde and
processed by immunofluorescence assay (IFA) using an anti-WNV NS3 antibody and antibodies
to Nestin for NPCs, GFAP for astrocytes, MAP2 for PMNs and CTIP2 for MNs (Figure 3.1B-D).
In NPC cultures 50% of the cells were infected by 48 hpi and 80% by 60 hpi while for both types
of neurons, 80% were infected by 48 hpi. The NPCs showed a decrease in the percent of infected
cells by 72 hpi (Figure 3.1E). This was likely due to infected cells dying. In astrocyte cultures,
20% of the cells were infected at 24 hpi and 60% were infected by 48 hpi (Figure 3.1E). The
astrocyte cultures were rapidly killed by WNV NY99 infection as there were almost no attached
cells remaining at 60 hpi (Fig 3.1E). These results indicate that WNV NY99 can efficiently infect
and replicate in the four hiPSC-derived cell types.

NY99 infection leads to caspase-3-dependent apoptosis in CNS cells
Neuronal cell death due to caspase-3-dependent apoptosis is a major contributor to CNS
disease and death from WNV infection in mice (Samuel, Morrey et al. 2007). To determine the
level of caspase-3-dependent apoptosis in hiPSC-derived cells infected with WNV, Matri-gel
coated coverslips with NPCs, PMNs, or astrocytes were infected with NY99, fixed with 4%
paraformaldehyde (PFA) at different times post infection, and then processed for IFA with an
antibody for cleaved caspase 3 (Casp3+) (Figure 3.2A-D). Twenty percent of the NPCs were
Casp3+ by 48 hpi and nearly 40% were positive by 72 hpi. Less than 5% of the mock infected cells
were Casp3+ (Figure 3.2B). Four percent of the infected neurons were Casp3+ at 24 hpi and 12%
were Casp3+ positive by 72 hpi (Figure 3.2D). The astrocytes showed no detectable caspase-3
staining at any of the times tested after infection.
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Figure 3.2. NY99 infection causes caspase-3-dependent cell death in NPCs and neurons.
Cultures of A) NPCs or C) neurons seeded on coverslips were infected with NY99 (MOI=0.5) and
were then processed for IFA with anti-cCasp3 antibody. B) Quantification of cCasp3 staining in
infected and mock infected NPCs. D) Quantification of cCasp3 staining in infected and mock
infected neurons. E) Neurons or H) NPCs were infected with NY99 and then treated with 20 µM
emricasan in 1% DMSO or with 1% DMSO alone for up to 120 hours. E) Representative image
of neurons treated with emricasan and then stained with anti-cCasp3 antibody. F) Quantification
of cCasp3 staining in emricasan treated neurons and DMSO control cells. G) Viral titers from
infected neurons with emricasan and without treatment. H) Representative IFA image of NPCs
with and without emricasan treatment then stained with anti-cCasp3 antibody. F) Quantification
of cCasp3 staining in emricasan treated NPCs and DMSO control cells G) Viral titers from infected
NPCs with or without emricasan treatment. Each data point represents the mean from three
biological replicate. Error bars are S.E.M.s ***p<0.005; student’s unpaired t-test.

49

Emricasan is a pan-caspase inhibitor that is currently undergoing phase 2 clinical trials for
treatment of liver disease (Sumida and Yoneda 2017). A recent screen of small-molecule inhibitors
of
Zika infection in NPCs and astrocytes showed emricasan could prevent caspase-3-dependent cell
death following infection (Xu, Lee et al. 2016). The effectiveness of emricasan in protecting WNV
infected CNS cells from caspase-3-dependent apoptosis was assessed. Following infection with
NY99, NPCs and PMNs were incubated with emricasan or a 1% DMSO control for up to 120 hpi
and analyzed by IFA using the Casp3+ antibody (Figure 3.2E, H). Casp3+ staining in both cell
types treated with the drug was significantly lower at all times up to 72 hpi compared to the DMSO
control (Figure 3.2F, I). The viral titer was determined at each time tested starting at 36 hpi (Figure
3.2G, J). Emricasan treatment had little effect on the virus titer produced by NPCs compared to
that produced by the DMSO control cells at any of the times tested (Figure 3.2J). Neuron cultures
treated with emricasan produced similar virus titers to the DMSO control cultures through 72 hpi
whereas the titers declined thereafter in the DMSO treated cells but remained high in the drug
treated cultures (Figure 3.2G). The ability of caspase-inhibited neurons to maintain viral
replication at high levels suggested a possible mode for the maintenance of a persistent infection.

Analysis of the effects of antiviral compounds on WNV NY99 replication in NPCs and in
astrocytes
A high-throughput screen of small molecule inhibitors against ZIKV infection in SNB-19
cells yielded two candidate drugs that inhibited ZIKV infection in NPCs and in astrocytes (Xu,
Lee et al. 2016). Niclosamide is an FDA-approved drug that has been used to treat tapeworm
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Figure 3.3. Analysis of the effect of Niclosamide or PHA-690509 treatment of NY99 infected
NPCs on WNV replication. Cultures of NPCs were infected with NY99 (MOI=0.5). After
incubation with virus, the cells were washed and media was replaced that contained 1% DMSO
with increasing concentrations of Niclosamide or PHA-690509 or 1% DMSO alone for 48 hours.
A) Supernatants from infected cells were assessed for infectious virus by plaque assay on BHK
cells. B) Cells seeded on coverslips were processed for IFA using an anti-dsRNA antibody and the
number of infected cells quantified using Volocity software. C) Representative Western blot of
cell lysates from either Niclosamide or PHA-690509 treated NPCs alongside DMSO control. D)
Quantification of NS3 protein bands from Western blots by densiometric analysis using ImageJ
software. NS3 band intensity was normalized to actin band intensity and measurements are relative
to the DMSO control. Each data point represents the means from three biological replicates. Error
bars are S.E.M. *p<0.05; **p<0.01; ***p<0.005; ****p<0.001 by One-way ANOVA
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infections in humans for 50 years (Kadri, Lambourne et al. 2018). PHA-690509 is an experimental
cyclin-dependent kinase (CDK) inhibitor with no known therapeutic applications. These two
compounds were tested for antiviral activity against WNV NY99 in NPCs and astrocytes. Cells
seeded on Matrigel-coated coverslips in 24 well plates and also in Matri-gel coated 12 well plates
without coverslips were infected with NY99 at an MOI=0.5. Media containing increasing
concentrations of either Niclosamide or PHA-690509 in 1% DMSO were then added to the cells
after the 1 hour absorption period. At 48 hpi, the supernatant was removed from the 24 well plates
and the coverslips were fixed with 4% PFA and processed for IFA. Cell lysates from the 12 well
plates were collected in RIPA buffer and analyzed by Western blotting.
Niclosamide treatment reduced the virus yield produced by NPCs (Figure 3.3) and
astrocytes (Figure 3.4) in a dose dependent manner. Treatment of NPCs with Niclosamide
decreased the viral titer by 1000-fold compared to the DMSO control at concentrations of 0.3 µM
and 0.9 µM (Figure 3.3A). In contrast, treatment of astrocytes with 0.9 µM of Niclosamide
decreased the virus yield by 10-fold (Figure 3.4A). The percent of cells infected was determined
by IFA staining with anti-NS3 antibody in NPCs and with anti-dsRNA antibody in astrocytes. The
percent of NPCs that showed a positive IFA signal for a viral marker after treatment with 0.3 µM
Niclosamide was only 5% at 48 hpi and less than 1% after treatment with 0.9 µM Niclosamide.
Eighty percent of the DMSO control cells were viral marker positive (Figure 3.3B). The percent
of infected astrocytes decreased from 60% in the DMSO control cultures at 48 hpi to 30% after
treatment with 0.9 µM of Niclosamide (Figure 3.4B). Viral protein translation was reduced by
treatment of NPCs with all doses of Niclosamide tested as assessed by Western blotting for viral
NS3 protein (Figure 3.3C, D). NS3 levels were also lower in astrocytes after treatment with 0.9
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Figure 3.4. Analysis of the effect of Niclosamide or PHA-690509 treatment of NY99 infected
astrocytes on WNV replication. Cultures of astrocytes were infected with NY99 (MOI=0.5).
After incubation with virus, the cells were washed and media was replaced that contained 1%
DMSO with increasing concentrations of Niclosamide or PHA-690509 or 1% DMSO alone for 48
hours. A) Supernatants from infected cells were assessed for infectious virus by plaque assay on
BHK cells. B) Cells seeded on coverslips were processed for IFA using an anti-dsRNA antibody
and the number of infected cells quantified using Volocity software. C) Representative Western
blot of cell lysates from either Niclosamide or PHA-690509 treated astrocytes alongside DMSO
control. D) Quantification of NS3 protein bands from Western blots by densiometric analysis using
ImageJ software. NS3 band intensity was normalized to actin band intensity and measurements
are relative to the DMSO control. Each data point represents the means from three biological
replicates. Error bars are S.E.M. ***p<0.005; ****p<0.001 by One-way ANOVA
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µM Niclosamide for 48 hpi (Figure 3.4C, D). These data indicate that Niclosamide has antiviral
activity against a WNV NY99 infection in both NPCs and astrocytes but is more effective in NPCs.
PHA-690509 reduced the virus yield in NPCs by ~5-fold at 48 hpi but only at a concentration of
9 µM (Figure 3.3A). In astrocytes, treatment with 9 µM of PHA-690509 decreased the virus yield
by 10-fold at 48 hpi (Figure 3.4A). Treatment of NPCs with PHA-690509reduced the percent of
detectable infected cells from ~80% in the DMSO control to 65% (3 µM) or to 20% (9 µM) at 48
hpi (Figure 3.3B). In astrocyte cultures PHA-690509 treatment decreased the percent of infected
cells from 60% in the DMSO control to 30% (3 µM) and 10% (9 µM) (Figure 3.4B). Viral protein
translation inhibition was observed at 48 hpi after treatment of NPCs (Figure 3.3C) and of
astrocytes (Figure 3.4C, D) with 3 or 9 µM of PHA-690509. These data indicate that PHA-690509
also has antiviral activity against WNV NY99 in NPCs and astrocytes.

Comparison of the efficiency of infections with WNV MAD78 and NY99 in NPCs and
astrocytes
WNV MAD78 can infect primary human brain astrocytes and primary mouse neurons
(Hussmann, Samuel et al. 2013) However, replication of other types of neural cells with this WNV
strain have not been tested. The replication kinetics of WNV NY99 and WNV MAD78 were
compared in human iPSC-derived cultures of NPCs and astrocytes. MAD78 efficiently infected
NPCs (Figure 3.5A,B). In NPCs, the MAD78 virus yield showed a more rapid increase at 12 hpi
compared to that of NY99 and reached peak titers at 24 hpi that were 5-fold higher than those of
NY99 at 24 hpi. The yields of the two viruses were similar at 48 hpi and 72 hpi (Figure 3.5A). The
percent of cells infected by MAD78 was higher than that for NY99 at 24 hpi (60% vs 25%) and at
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Figure 3.5. MAD78 infection in hiPSC-derived NPCs and astrocytes. Cultures of iPSC-derived
NPCs or astrocytes were infected with MAD78 (MOI=0.5) or NY99 (MOI=0.5). A, D)
Supernatants were harvested at indicated times and infectious viral titer determined by plaque
assay on BHK cells. B, E) Infected coverslips were fixed with 4% paraformaldehyde at the
indicated time points and processed for IFA with antibodies against WNV NS3. C) Infected NPCs
were processed for IFA with an anti-Casp3 antibody. The percentage of Casp3+ cells was
quantified using Volocity software. Each data point is the average of three biological replicates.
Error bars are S.E.M.
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48 hpi (85% vs 50%) (Figure 3.5B). MAD78 activation of caspase-3 was assessed by IFA (Figure
3.5C). The percent of Casp3+ cells in MAD78 infected NPCs cultures was very low and
comparable to that in mock infected cultures at all times tested up to 72 hpi (Figure 3.5C). These
data indicate that NPCs are permissive to infection by MAD78 and that MAD78 replicates more
efficiently than NY99 in these cells. MAD78 did not activate caspase-3 cleavage in these cells by
72 hpi (Figure 3.5C).
In astrocyte cultures, MAD78 had the same number of infected cells as NY99 (~25%) but
fewer cells were infected in the MAD78 cultures compared to NY99 at 48 hpi (25% vs 60%). The
observation that the percentage of infected astrocytes did not change between 24 and 48 hpi in
MAD78 infected cultures indicated that few secondary infections had occurred. The percent of
MAD78 infected astrocytes was ~50% at 72 hpi (Figure 3.5E). Virus titers produced by MAD78
infected astrocytes rose faster than those produced by NY99 infected astrocytes before 24 hpi but
were 0.5 log lower at 24 hpi and 1 log lower at 48 hpi and 72 hpi than NY99 (Figure 3.5C). These
data are similar to those obtained by a study of MAD78 infection in primary human astrocytes
(Hussmann, Samuel et al. 2013). The data indicate MAD78 is capable of infecting astrocytes, but
does not spread efficiently in these cultures and does not produce as much infectious virus as
cultures infected with NY99.

Transcriptome analysis of NPCs infected with either WNV MAD78 or NY99
To investigate the differential effects of MAD78 and NY99 infections on gene expression
in NPCS, RNA-seq was performed. Cultures of NPCs were infected with MAD78 or NY99
(MOI=2). Efficient infection of the NPCs by each virus was confirmed by IFA with anti-dsRNA
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Figure 3.6. Comparative transcriptome analysis at 12 hpi of NPCs infected with NY99 or
MAD78. A) Total number of DEGs differentially regulated by both viruses with a 2-D Venn
diagram showing common upregulated (green) and downregulated (gold) DEGs in NPCs at 12 hpi
by NY99 (represented by warm colors) and MAD78 (represented by cool colors). Both viruses
were used at MOI=2. B-E) GO enrichment analysis of DEGs using the terms biological process,
molecular function, pathway and keywords. A Benjamini-Hochberg false discovery procedure was
used and any term with p>0.05 was excluded. The histograms show enrichment terms of B)
MAD78 12 hpi upregulated DEGs, C) NY99 12 hpi upregulated DEGs, D) MAD78 12 hpi
downregulated DEGs and E) NY99 12 hpi downregulated DEGs.
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antibody. Total cellular RNA was extracted at 12 and 24 hpi from infected and mock infected
cultures on replicate cultures. The RNA was analyzed by MiSeq with PE reads by Novogene. At
12 hpi, there were a total of 1048 DEGs in MAD78 infected NPCs and 1070 DEGs in NY99
infected NPCs, with 594 of these genes upregulated by both viruses (Figure 3.6A). The 454 unique
MAD78 DEGs constituted 43% of the total MAD78 DEGs, and the 475 unique NY99 DEGs
constituted 44% of the total NY99 DEGs. At 24 hpi, there was a total of 7735 DEGs in MAD78
infected NPCs and 7405 DEGs in NY99 infected NPCs with 5791 common DEGs (Figure 3.7F).
There were 1921 unique DEGs in MAD78 infected NPCs (25% of total) and 1584 DEGs in NY99
infected NPCs (21% of total) at 24 hpi (Figure 3.7F).
To determine what cellular processes were enriched by infections with these two viruses,
up- and down-regulated DEGs with a ≥ 1.5-fold change in expression at 12 hpi and ≥ 2 fold change
in expression at 24 hpi were analyzed for GO analysis using DAVID (Figures 3.6 & 3.7). GO
enrichment analysis was limited to cellular pathways, biological processes, molecular function,
and keywords. Three types of analyses were performed (1 the common DEGs that were altered by
both viruses in infected cells, (2 the virus strain-specific DEGs, (3 and all of the DEGs for each
virus that were upregulated above the established thresholds.
The MAD78 up-regulated DEGs in infected NPCs at 12 hpi were enriched for “protein
processing in the ER”, “endoplasmic reticulum”, and “ER unfolded protein response”, with a total
of 51 genes comprising these three categories (Figure 3.6B). “Antiviral defense”, “type I interferon
signaling pathway”, and “defense response to virus” were also enriched with a total of 20 genes
(Figure 3.6B). NY99 DEGs in infected NPCs at 12 hpi were enriched for “antiviral defense”, “type
I interferon signaling pathway”, “defense response to virus”, and “response to virus” with 26 genes
in these categories (Figure 3.6C). NY99 DEGs were also enriched for endoplasmic reticulum stress
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Figure 3.7. Comparative transcriptome analysis at 24 hpi of NPCs infected with NY99 or
MAD78. A) Total number of DEGs differentially regulated by both viruses with a 2-D Venn
diagram showing common upregulated (yellow) and downregulated (orange) DEGs in NPCs at 24
hpi by NY99 (represented by warm colors) and MAD78 (represented by cool colors). Both viruses
were used at MOI=2. B-G) GO enrichment analysis of DEGs using the terms biological process,
molecular function, pathway and keywords. A Benjamini-Hochberg false discovery procedure was
used and any term with p>0.05 was excluded. The histograms show enrichment terms of B)
MAD78 12 hpi upregulated DEGs, C) NY99 12 hpi upregulated DEGs, D) MAD78 12 hpi
downregulated DEGs and E) NY99 12 hpi downregulated DEGs. F) Unique DEGs that were only
upregulated in MAD78 infected NPCs. G) Unique DEGs that were only downregulated in NY99
infected NPCs.
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genes with 18 genes in the categories “IRE-1-mediated unfolded protein response”, “protein
processing in ER”, and “ER chaperone complex” (Figure 3.6C).
Up and downregulated DEGs common to infections with both viruses at 12 hpi were
analyzed for enrichment. “Focal adhesion”, “endoplasmic reticulum”, “extracellular matrix
organization” and “protein processing in endoplasmic reticulum” were up regulated with 49, 65,
27 and 26 genes in each category, respectively (Figure 3.6D). Both viruses infections had down
regulated DEGs enriched for “developmental protein”, “neuron differentiation”, “neuron
development”, and “neurogenesis” with 44 common DEGs shared by both viruses that fit into
these four categories (Figure 3.6E).
MAD78 upregulated DEGs in infected NPCs at 24 hpi were enriched for “protein
processing in endoplasmic reticulum”, “antiviral defense”, “stress response”, and “IRE1-mediated
unfolded protein response” with 37, 29, 24 and 19 proteins in each category, respectively (Figure
3.7B). MAD78 and NY99 down regulated DEGs were enriched for “glycoprotein”, “signal”,
“calcium”, and “extracellular matrix” with 844, 741, 158, and 221 genes in each category
respectively with a total of 1002 individual genes (Figure 3.7E). “Nervous system development”
and “neurogenesis” were also downregulated by both viruses with 149 genes in these two
categories (Figure 3.7E). NY99 infection upregulated DEGs were enriched for ER stress responses
with 74 individual genes in four categories related to protein processing in the ER (Figure 3.7C).
NY99 infected NPCs were also enriched for “antiviral defense” with 21 genes in this category
(Figure 3.7C).
Common DEGs that were upregulated by the two viruses at 24 hpi were enriched for
“protein binding”, “protein transport”, and “protein processing in the ER”, with 2538 individual
genes in these three categories (Figure 3.7D). “Alternative splicing” was also enriched with 1874
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DEGs and “apoptosis” with 148 DEGs (Figure 3.7D). GO analysis of DEGs at 24 hpi that were
unique to MAD78 or to NY99 infection revealed several terms that were oppositely regulated by
the two virus infections (Figure 3.7F, G). The term “nucleus” was enriched in upregulated MAD78
DEGs with 519 unique DEGs but 313 unique NY99 DEGs were downregulated in this category.
While the term “alternative splicing” contained 1874 common upregulated DEGs, there were also
837 unique upregulated DEGs for MAD78 and 548 unique downregulated DEGs for NY99 (Figure
3.7F, G). Additionally, the terms “cell cycle” and “cell division” had 101 and 72, respectively,
unique upregulated DEGs for MAD78 and had 61 and 35, respectively, unique downregulated
DEGs for NY99 (Figure 3.7F, G).

WNV infection of CNS cells modulates the cell cycle and decreases cell proliferation
An RNA-seq analysis of NPCs infected with ZIKV and DENV indicated the expression of
genes associated with the cell cycle and cell proliferation was downregulated by both viruses
(Zhang, Hammack et al. 2016). Our analysis showed that infection of NPCs by WNV NY99 also
modulated the expression of genes associated with the cell cycle (Figure 3.7 F, G, Table 3.1 &
3.2). Upregulated DEGs were associated with negative regulation of the G1/S phase transition
(Table 3.1). Downregulated DEGs were associated with initiation of DNA synthesis (Table 3.2).
Of particular note were the downregulated minichromosome maintenance complex (MCM)
proteins which are necessary for initiating DNS synthesis at the G1/S phase transition (Deegan
and Diffley 2016). To further investigate, 165 up- and downregulated DEGs at 24 hpi that enriched
for the terms “cell cycle” and “cell division” were analyzed by protein-protein and genetic
interaction network analysis using GeneMania. GeneMania searches biological datasets for
information on genes that are confirmed to physically interact, either directly or in complexes, or
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Table 3.1. List of DEGs that were upregulated by NY99 infection in NPCs

Table 3.2. List of DEGs that were downregulated by NY99 infection in NPCs
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are part of genetic interaction networks (Warde-Farley, Donaldson et al. 2010) (Figure 3.8). The
protein-protein interaction network analysis revealed that many of the genes more centrally located
in the network, meaning these genes products have multiple interaction partners within the
network, were downregulated DEGs in NY99 infected NPCs. All but two of these twelve
downregulated DEGs were associated with “DNA replication” (Figure 3.8). Many of the
upregulated DEGs were found at the periphery of the network, meaning that they only have a few
interacting partners (Figure 3.8). This finding suggests that these gene products are targeting key
regulators in the network. For example, the transcription factor AHR has a genetic link with cyclindependent kinase inhibitor 1a (CDKN1A), which in turn has multiple interaction partners
including CDK2 (Marlowe and Puga 2005) (Figure 3.8). These data indicate that modulation of
the expression of particular sets of genes by NY99 infection of NPCs may inhibit DNA replication
and cell cycle progression.
To analyze the effect of WNV-mediated cell cycle perturbation on infected neural cells,
glioblastoma cells (SNB-19) and NPCs were infected with NY99 (MOI=2) or mock infected and
the cells were trypsinized, harvested and counted with a hemocytometer either just before infection
and at 24 and 48 hpi (Figure 3.11A, B). To account for cells that detached due to the effects of the
infection, supernatants were also harvested and centrifuged to obtain the cells that were floating in
the media and these were added to the trypsinized cell samples. At 24 and 48 hpi, the number of
SNB-19 cells was significantly greater (p<0.001) in the mock infected wells compared to the NY99
infected wells (Figure 3.11A). The ratio of mock infected SNB-19 cells to virus infected cells was
1.5x at 24 hpi and ~2x at 48 hpi (Figure 3.11C). At 24 hpi the number of mock infected and NY99
infected NPCs was similar but at 48 hpi the number of mock infected NPCs was significantly
higher (p<0.01) than the number of NY99 infected cells (Figure 3.11B). The ratio of mock infected
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Figure 3.8. Protein-protein interaction network analysis of cell cycle-related DEGs during
infection of NPCs by NY99. A protein-protein interaction and genetic interaction network map
highlighting genes that are involved in “G1/S transition of mitotic cell cycle”, “DNA replication”,
“cell cycle arrest” and “regulation of cell cycle arrest” and are DEGs in NY99 infected NPCs.
Genes closer to the center have more interactions with other members of the network while genes
toward the periphery have fewer numbers of interacting partners. Genes connected by red lines
have direct protein-protein interactions whereas genes with green lines are genetically connected.
The red circles indicate downregulated DEGs and the green circles indicate upregulated DEGs.
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Figure 3.9. Inhibition of CNS cell proliferation by a NY99 infection. NY99 infected (MOI=2)
A) SNB-19 cells and B) NPCs were counted at the indicated hpi. Zero points were cells counted
before infections. C) Ratio of number of cells in mock cultures to those in infected cultures. D)
SNB-19 cells were infected with NY99 (MOI=2), fixed by 4% PFA at the indicated hpi, and
stained with anti-Ki67, anti-GFAP, and anti-NS3 antibodies. Images shown are representative of
three biological repeats. E) Ki67+ nuclei were quantified using Volocity software. Data points are
means from three biological replicates. Error bars are S.E.M. ****p<0.001; One-way ANOVA.
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NPCs to NY99 infected NPCs was 1.6x at 48 hpi (Figure 3.11C). These data indicate that NY99
infection of both SNB-19 cells and NPCs inhibited cell division.
To determine if cell proliferation was inhibited in the infected cultures, SNB-19 cells
infected with NY99 were fixed with 4% PFA and processed for IFA using anti-WNV NS3
antibody, anti-GFAP antibody as a cell marker, and an antibody to the cell proliferation marker
Ki67, which binds to mitotic chromosomes after nuclear envelope disassembly (Cuylen, Blaukopf
et al. 2016) (Figure 3.11D). At 24 hpi, the percent of cells with Ki67+ nuclei was similar between
NY99 infected and mock infected SNB-19s cultures. At 48 hpi, there were significantly more
(p<0.001) cells with Ki67+ nuclei in the mock infected SNB-19 cultures than in the NY99 infected
cultures (Figure 3.11D). These data indicate that infection with WNV NY99 does inhibit cell
proliferation in SNB-19 cells.
Cell cycle arrest can be initiated by the cell at multiple steps in the cell cycle in response
to a wide variety of stimuli. Ki67-binding, as detected in proliferation assays, occurs at the G2
phase in mitotic cells, which is the last phase before mitosis (Whitfield, George et al. 2006). The
analysis of DEGs downregulated by WNV at 24 hpi indicated downregulation of the MCM family
of genes, which are involved in DNA replication, and indicates that cell cycle arrest likely occurs
prior to the G2 phase (Figure 3.9). To determine when in the cell cycle the WNV-mediated cell
cycle perturbation occurs, DNA synthesis was assessed by a BrdU-pulse assay. The efficiency of
BrdU incorporation and the total DNA content by propidium iodide (PI) staining was assessed by
flow cytometry (Figure 3.11B, C). For both mock and infected cells at the time of release, the
percent of cells in S-phase was extremely low 0.82% and 0.66% respectively. The percent of
untreated, mock infected cells was 21.3% (Figure 3.12B, C). At 2 and 4 hours post release (hpr),
the percent of cells in early and late S-phase in mock infected cells and WNV-infected cultures
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Figure 3.10. Analysis by BrdU pulse-labeling of DNA synthesis in SNB-19 cells infected with
NY99. A) Timeline of protocol for BrdU pulse-labeling experiment. SNB-19 cells were infected
with NY99 (MOI=2). After infection, thymidine was added to the cells for 18 hours. The thymidine
was then removed and the DNA were incubated with BrdU at the indicated times post release.
Cells were harvested, labeled for DNA content by propidium iodide staining, and analyzed by flow
cytometry. B) BrdU-labeling of cells prior to thymidine release. C) BrdU-pulse labeling of cells
after thymidine release. Images shown are representative of two biological replicates.
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was approximately equal (Figure 3.12C). At 6 hours, 29.6% of the mock infected cells were in
early S-phase and 48.9% of the cells were in late S-phase, while 40.4% of the infected cells were
in early
S-phase and 34.8% were in late S-phase. At 8 hpr, 6.65% of the mock infected cells were
in early S-phase and 30.5% of the cells were in the G2 phase while 14.8% of the infected cells
were in early S-phase and only 15.9% were in the G2 phase. Additionally, 26.2% of the cells in
infected cultures were in the G1 phase but only 18.9% of the cells in the mock cultures were in the
G1 phase. At 10 hpr, 30.7% of the mock infected cells were in the G2 phase and 19.9% were in
the G1 phase. In the 10 hpr infected cultures 16.6% of the cells were in the G2 phase and 25.1%
were in the G1 phase (Figure 3.12C). These data indicated that WNV-infected SNB-19 cells
experienced G1/S phase arrest following release from thymidine-mediated cell cycle arrest.
To determine if cell cycle arrest had a beneficiary effect on virus replication, S-phase arrest
was induced through treatment of cells with either 2 mM of thymidine or 12 µM of aphidicolin
(APH). APH binds to the active site of B-family DNA polymerases, preventing DNA synthesis
and arresting cells at the G1/S interface (Baranovskiy, Babayeva et al. 2014). SNB-19 cells were
incubated with 2 mM thymidine to synchronize their cell cycles, released for 12 hours, and then
infected with NY99 in media containing 1% DMSO and either 2 mM thymidine or 12 µM APH
or 1 % DMSO alone. Infected cells were analyzed by Western blotting with an anti-NS3 antibody
(Figure 3.13A) and by qRT-PCR (Figure 3.13C). Treatment of cells with thymidine increased viral
NS3 levels significantly (p<0.05) over the DMSO control cells but APH treatment had little effect
(Figure 3.13A, B). Intracellular viral genomic RNA levels were elevated in thymidine and APH
treated cultures compared to the DMSO control cultures at 24 hpi but not 48 hpi (Figure 3.13C).
These data indicate that S-phase arrest has a beneficiary effect on WNV infection in SNB-19 cells.
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Figure 3.11. Effect of cell cycle arrest on WNV infection of SNB-19 cells. Cultures of SNB-19
cells were treated with 2 mM thymidine for 12 hours and then were released for 12 hours. The
cells were then incubated with either 2 mM thymidine, 12 µM APH, or DMSO control for 16
hours. The cells were then infected with NY99 (MOI=1). A) Representative western blot image of
WNV infected cell lysates harvested at 24 hpi. Membranes were probed with anti-NS3 antibody.
B) Quantification of relative NS3 intensity from three biological repeats. *p<0.05; two-tailed ttest. C) Total intracellular RNA from SNB-19 cells was extracted at 24 hpi and 48 hpi and analyzed
by RT-qPCR. Representative data from one biological replicate is shown. Three biological
replicates were performed.
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Astrocytes infected with WNV NY99 express pro-inflammatory cytokine genes
Astrocytes infected with WNV NY99 produce several inflammatory cytokines that can
contribute to cell death and may also contribute to neuroinvasion and CNS disease in mice (Wang,
Town et al. 2004, van Marle, Antony et al. 2007, Choi, Lee et al. 2014). To determine if NY99
infection of the hiPSC-derived astrocytes increased expression of pro-inflammatory cytokine
genes, astrocytes infected with NY99 (MOI=1) were analyzed by RNA-seq. WNV-infected and
mock infected astrocyte monolayers were lysed with TRI Reagent at 24 and 48 hpi and the
intracellular RNA was isolated by phenol chloroform extraction. Mock infected cultures were used
to determine the fold change of DEGs. The RNA was analyzed by MiSeq with paired-end reads
by Novogene. Infection efficiency was assessed on replicate infected cultures grown on coverslips
by IFA using an anti-dsRNA antibody. The infection rate was 35% at 24 hpi and 72% at 48 hpi
(Data not shown).
There were 9448 and 9863 up-regulated NY99 DEGs at 24 and 48 hpi, respectively, with
6945 common upregulated DEGs between the two times (Figure 3.8A). There were 9007 and
12093 downregulated NY99 DEGs at 24 and 48 hpi, respectively, with 6708 downregulated DEGs
common to both times (Figure 3.8B). GO enrichment analysis using DAVID was performed for
the terms biological process, molecular function, keywords, and cellular pathway. Genes
associated with immune response against viruses were upregulated at both times compared to
mock infected cells (Figure 3.8C, D). At 48 hpi, upregulated DEGs were enriched for “cytokine”
and “apoptosis” (Figure 3.8D). At 24 hpi and 48 hpi, the expression levels of IFNL1, CCL3, CCL5,
interleukin-6 (IL-6), CD40 and CD70 were highly upregulated (Figure 3.9A). Increased expression
levels of IFNβ, CXCL10, OAS2, and OAS3 were also observed (Figure 3.9A).
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Figure 3.12. Transcriptome analysis of hiPSC-derived astrocytes infected with NY99. A &
B) 2-D Venn diagram of A) upregulated DEGs and B) downregulated DEGs in NY99 infected
iPSC-derived astrocytes (MOI=2). GO analysis for enrichment of biological process, molecular
function, pathway and keywords that were C & D) upregulated by NY99 infection at C) 24 hpi
and D) 48 hpi and E & F) downregulated at E) 24 hpi and F) 48 hpi.
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To test if inflammatory cytokines were being secreted by hiPSC-derived astrocytes infected
with WNV NY99, and to see if a WNV MAD78 infection also induced pro inflammatory cytokines
to the same level, supernatants harvested at 48 hpi and 60 hpi from NY99 and MAD78 infected
cultures (MOI=2) of hiPSC-derived astrocytes were assayed by ELISA for IL-6, CXCL10, and
CCL5 (Figure 3.9B-D). At 48 hpi, the secretion of all three proteins was elevated but the levels
were not significantly different between the supernatants from the two different virus infections
(Figure 3.9B-D). At 60 hpi, the NY99-infected astrocytes produced significantly higher levels of
CCL5 (Figure 3.9B) and CXCL10 (Figure 3.8C) compared to the MAD78 infected astrocytes. The
observed level of IL-6 in the from MAD78 and NY99 infected astrocytes may be inaccurate as it
was over the detection limit of the assay. These results show that infection of astrocytes by both
viruses induces secretion of pro-inflammatory cytokines CXCL10, IL-6 and CCL5.

DISCUSSION
WNV is currently the leading cause of virus-induced encephalitis in the United States
(Burakoff, Lehman et al. 2018). Studies in mice have indicated that WNV can infect several
neuronal subtypes, astrocytes and microglia (Diniz, Da Rosa et al. 2006, Cho, Proll et al. 2013,
Quick, Leser et al. 2014). Similar to the findings in mice, primary human astrocytes and neurons
are permissive to infection by pathogenic WNV NY99 (Cheeran, Hu et al. 2005). In the current
study, the pathogenic WNV lineage I strain NY99 was shown to efficiently infect and replicate in
cultures of human iPSC-derived NPCs, astrocytes, pre-mitotic neurons and post-mitotic neurons
(Figure 3.1). These data support previous findings in the literature using a new model for studying
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Figure 3.13. WNV infected astrocytes produce pro-inflammatory cytokines. A) Increased
expression of several pro-inflammatory genes revealed by RNA-seq analysis of NY99 infected
astrocytes at 24 and 48 hpi. ELISA was performed on supernatants from MAD78 and NY99
infected astrocytes to detect secreted B) CCL5, C) CXCL10, and D) IL-6. Each histogram is the
mean from three replicate experiments and error bars represent S.E.M. *p<0.05, **p<0.01,
student’s t-test, two tailed.
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human WNV CNS disease and implicate NPCs as targets of WNV infection for the first time.
NPCs are CNS stem cells that are important components of not only normal fetal CNS
development but also adult CNS maintenance, especially following injury (Bond, Ming et al.
2015). Patients with confirmed WNV-mediated CNS disease had significant neuropsychological
impairment one year after symptoms had resolved, suggesting long term damage to the CNS
(Sadek, Pergam et al. 2010). The ability of WNV to directly infect human NPCs and cause
apoptosis via caspase-3 cleavage (Figure 3.2B) could reduce the pool of NPCs available for the
CNS repair that occurs following clearance of WNV from the brain, which would contribute to
prolonging CNS impairment.
The non-pathogenic WNV MAD78 also infected astrocytes (Figure 3.5D) and caused
secretion of pro-inflammatory cytokines (Figure 3.9) but did not spread as efficiently in these cells
as the pathogenic WNV NY99 (Figure 3.5E). The percent of astrocytes infected by the two viruses
was comparable at 24 hpi. At 48 hpi the percent of NY99 infected cells had increased but in the
MAD78 infected cultures, the percent of infected cells had not increased (Figure 3.5E). A more
limited ability of MAD78 to infect astrocytes could prevent this virus from efficiently crossing the
blood brain barrier and causing neuroinvasive disease (Winkelmann, Luo et al. 2016).
Interestingly, at 24 hpi, the viral yield produced by MAD78 infected astrocytes was only 0.5 log
lower than that produced by NY99 and only 1 log lower by 48 hpi, suggesting that MAD78 virus
production was efficient in the astrocytes that were infected compared to NY99. It was the
secondary rounds of infection by progeny MAD78 virus that was impeded. A suggested
explanation in a previous study is that the progeny MAD78 virus produced from astrocytes cannot
efficiently infect astrocytes due to astrocyte-specific modifications to the viral structural proteins
that inhibit maturation of the virus particles in the golgi apparatus prior to viral egress (Hussmann,
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Vandergaast et al. 2014). This lack of ability to induce secondary rounds of infection may
contribute to the observed decreased cytokine production by astrocytes infected with MAD78
compared to NY99 (Figure 3.9).
This study reports the first comparative transcriptome analysis of hiPSC-derived NPCs
infected with NY99 and MAD78. Infection by either of these viruses activated ER stress pathways
and the unfolded protein response (UPR) by 12 hpi (Figure 3.6B, C). Activation and modulation
of the UPR and the ER stress response by DENV, ZIKV, JEV and WNV infections has previously
been reported (Blazquez, Escribano-Romero et al. 2014, Hou, Kumar et al. 2017). The role that
the UPR plays in viral replication is not well understood. ER stress leads to increased ER
membrane proliferation that can facilitate cell survival and also serve as a platform for virus
replication (Lee, Kuo et al. 2018). Activation of the IRE1-mediated unfolded protein response
results in excision of an intron from the transcription factor xbox-binding protein 1 (XBP1) mRNA
that stabilizes the transcription factor protein produced and this transcription factor upregulates
multiple UPR genes (Iranpour, Moghadam et al. 2016). Although XBP1 expression was
upregulated by infection with both WNV viruses at 24 hpi in NPCs, XBP1 expression was
previously shown not to be required for DENV or WNV replication (Iranpour, Moghadam et al.
2016, Lee, Kuo et al. 2018). The efficiency of cleavage of the xbp1 mRNA was not analyzed.
The translation of large amounts of viral protein and the insertion of these proteins into the
ER membrane could increase the accumulation of unfolded proteins in the cell. For both viruses,
DEG enrichment for genes involved in protein binding and protein transport was observed (Figure
3.7D). Protein binding DEGs were mainly comprised of chaperone proteins, such as the DNAJ
family of proteins. The DNAJ/Hsp40 family is a large group of proteins that facilitate cell survival
by assisting with proper protein folding using ATP-hydrolysis (Mogk, Bukau et al. 2018,
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Zarouchlioti, Parfitt et al. 2018). Flaviviruses may requisition host chaperone proteins to facilitate
replication. Two DNAJ family members, DNAJC14 and DNAJA1, have been previously
implicated as being important for flavivirus replication by YFV and JEV (Wang, Huang et al.
2011, Taguwa, Maringer et al. 2015). The contribution of other members of this family of proteins
to WNV infection is not known.
A recent analysis of infection outcomes in a mouse model of long term effects after
surviving WNV CNS disease indicated that NPCs differentiated into proinflammatory astrocytes
in response to WNV infection in the CNS and that this depletion of the NPC pool prevented
efficient CNS repair leading to prolonged CNS damage and behavioral dysfunction (Garber, Vasek
et al. 2018). The authors suggest that this switch was facilitated by the secretion of proinflammatory cytokines during infection (Garber, Vasek et al. 2018). Our RNAseq analysis
indicated that MAD78 and NY99 infected NPCs caused downregulation of DEGs associated with
“neurogenesis” and “nervous system development” (Figure 3.7E). Additionally, NY99 infection
induced increased expression of pro-inflammatory cytokines in astrocytes and infection of
astrocytes by both MAD78 and NY99 led to increased secretion of pro-inflammatory cytokines
(Figure 3.9). In addition to the induction of apoptosis in NPCs by infection with WNV NY99, this
could be an additional means by which WNV NY99 reduces the NPC population.
Cell cycle manipulation by DNA viruses that replicate in the nucleus of infected cells has
been observed. These viruses utilize the host DNA-synthesis machinery to facilitate the replication
of their DNA genomes. Several oncolytic viruses, such as human T-cell leukemia virus and human
papilloma virus, encode proteins that directly interact with cyclin proteins to facilitate cell cycle
entry into S-phase (Nascimento, Costa et al. 2012). Herpesviruses encode cyclin mimics that can
interact with the host cell cycle regulatory proteins (Nascimento, Costa et al. 2012). RNA viruses
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have also been shown to modulate the cell cycle although the reason for doing so remains unclear.
Infectious bronchitis virus infection arrests Vero cells in the G2/M phase and produced increased
viral yields in synchronized cells (Dove, Brooks et al. 2006). Chronic infection with Hepatits C
virus (HCV) induces G1 phase arrest in hepatocytes and this may be a major contributor to HCVrelated cirrhosis (Marshall, Rushbrook et al. 2005). Infection of human NPCs with ZIKV or DENV
decreased the expression of cell cycle progression genes (Zhang, Hammack et al. 2016). In the
current study, NPCs infected with WNV NY99 had decreased expression of cell cycle and mitosis
genes and showed decreased cell proliferation compared to mock infected cells (Figure 3.7G &
Figure 3.9B). In SNB-19 cells, S-phase arrest by treatment with thymidine had a positive effect on
WNV translation and genome RNA production (Figure 3.11B, C). Interestingly, treatment of SNB19 cells with aphidicolin, which causes cell cycle arrest at the G1/S interface, did not appear to
have a significant impact on NY99 replication (Figure 3.11B, C). The advantage of cell cycle
perturbations for the replication cycles NY99 and other flaviviruses are not known.
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4

CONCLUSIONS AND FUTURE DIRECTIONS

Characterization of components of flavivirus disease resistance in mice
The life cycle of RNA viruses occurs entirely in the cytoplasm of the host cell it infects
and interactions with host factors in the cell are major determinants of the outcome of infections
with RNA viruses. Mice express a single gene, Oas1b, which conveys resistance to all members
of the genus Flavivirus (Scherbik, Kluetzman et al. 2007). The finding that a single host gene can
have such broad antiviral activity means it is targeting a critical component that is unique to the
flavivirus life cycle. Work described in this dissertation and in previous studies (Scherbik,
Paranjape et al. 2006, Elbahesh, Jha et al. 2011) all indicate that Oas1b does not exert its antiflavivirus activity through activation of RNase L.
Mice expressing the resistant form of Oas1b produce decreased levels of viral RNA and
infectious virus. In the present study, this was observed both by direct observation of dsRNA
staining in infected brains and by measurement of viral plus strand RNA by qRT-PCR. The full
length, resistant form of Oas1b has a transmembrane domain that targets it to the ER membrane in
cells (Courtney, Di et al. 2012). Since flavivirus replication is associated with the ER membrane,
localization of Oas1b to the viral replication complex vesicles in the ER membrane of infected
cells is likely an important component of its anti-flavivirus activity. Future experiments should
seek to determine if Oas1b and its binding partners are located inside viral replication vesicles in
infected cells. Detection of a recombinant V5-tagged Oas1b protein that is expressed from an
oas1b mRNA together with detection of dsRNA with anti-dsRNA antibody by high resolution
imaging techniques, such as dSTORM imaging, in infected cells could be used to probe the
colocalization of Oas1b and viral replication vesicles. Additionally, the interior of the replication
complexes could be probed after ultracentrifugation to separate membranous components of the
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cell into discrete fractions by immunoblotting. This approach has been used with YFV infected
cells to determine the role of the host protein DNAJC14 in viral replication vesicle formation (Yi,
Yuan et al. 2012).
The role that Oas1b plays in inhibiting viral (+)RNA production will require additional
analysis. The most likely mechanism is through interaction with or effects on the functions of viral
nonstructural proteins in the viral replication complex. Serial passage of WNV in cells expressing
Oas1b yielded a virus mutant that had improved RNA production in resistant cells. The mutations
were located in the NS3 helicase domain and in the NS4A gene C-terminal 2K domain (Mertens,
Kajaste-Rudnitski et al. 2010). The flavivirus NS3 protein is found in the replication vesicles of
infected cells and hydrolyzes ATP as part of its helicase function that unwinds the viral dsRNA
and facilitates the synthesis of nascent genome RNA. NS4A is a cofactor for helicase activity but
not for ATPase activity (Shiryaev, Chernov et al. 2009). An in vitro study of DENV NS3 activity
showed that when the ATP concentration is low, NS3 switches from dsRNA unwinding to RNA
strand annealing (Gebhard, Kaufman et al. 2012). The presence of Oas1b and its binding partner
ABCF3, which both contain ATP-binding and ATPase domains, in the replication vesicles of
resistant infected cells could decrease the effective concentration of ATP available for NS3 and
result in inefficient dsRNA unwinding.
Infected brains from resistant mice showed decreased amplification of dsRNA staining
compared to susceptible mice at later times post infection even though the dsRNA staining patterns
were comparable in the brains of resistant and susceptible mice at early times after infection. The
observed amplification of the area and intensity of the dsRNA signal in susceptible infected cells
could be due to an increase in the size of the individual replication vesicles or an increase in the
number of vesicles. Expression of recombinant WNV NS4A-2K protein alone can induce ER
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membrane rearrangement in infected cells (Roosendaal, Westaway et al. 2006). The possibility of
an interaction between viral NS4A-2K with Oas1b and its binding partners that decreases the
formation of additional replication vesicles should be investigated.
Modulation of lipid homeostasis in infected cells is critical for efficient flavivirus
replication, which is dependent on the proliferation and modification of cell cytoplasmic
membranes. The lipid profile of the ER membrane in host cells is dramatically altered during
infection with flaviviruses. Cholesterol is particularly important to facilitate membrane bending
for vesicle formation (Martin-Acebes, Vazquez-Calvo et al. 2016). Flavivirus infection enhances
cholesterol biosynthesis in infected cells and reroutes cellular cholesterol to viral replication
vesicles in the ER membrane (Mackenzie, Khromykh et al. 2007). The Oas1b binding partner
Orp1L has a cholesterol sensing domain and functions in the endosomal pathway to transfer late
endosome-associated cholesterol to the ER membrane (Courtney, Di et al. 2012, Zhao and
Ridgway 2017). Oas1b interaction with Orp1L during virus infection may inhibit this activity,
resulting in inefficient ER membrane rearrangement by the virus and loss of replication vesicle
formation. Further studies of the involvement of Orp1L in the resistance phenotype are needed.

Characterization of the response of human pluripotent stem cell-derived CNS cells to
infection with avirulent and virulent strains of WNV
WNV NY99 efficiently infects human NPCs, astrocytes, PMNs and MNs (Figure 3.1 &
3.2). This broadly covers all of the major cell types of the CNS as being permissive to infection
by NY99. In developing fetuses, NPCs differentiate into radial glial cells that then differentiate
into glial cell subtypes, such as astrocytes, or into different neuronal subtypes, such as Purkinje
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cells or motor neurons (Lui, Hansen et al. 2011). Neuronal subtypes in mice have shown variation
in their baseline expression levels of ISGs that influence susceptibility to infection by RNA viruses
(Cho, Proll et al. 2013). The degree of susceptibility of different human neuronal subtypes to WNV
infection warrants further investigation. There are protocols currently being developed to
differentiate hiPSC-derived cells into specific neuronal subtypes (Mukhtar and Taylor 2018). The
recent development of human 3D neural organoids formed by self-assembly of stem cells provides
a means of studying the virus susceptibility of different neuronal subtypes as they arise naturally
during the growth of the organoid (Lancaster, Renner et al. 2013, Qian, 2016 #652).
There is emerging evidence of the role of cytokines in not only controlling inflammation
in response to tissue injury or pathogen infection but also in dictating the differentiation of stem
cells including NPCs. NPC-derived radial glial cells in the brain self-renew to maintain a pool of
neural cell progenitors that can differentiate into neurons or astrocytes in response to Jak-STAT
signaling (Deverman and Patterson 2009). In mice infected with WNV, IL-1 production by
myeloid cells facilitated a switch in NPC differentiation from neurogenesis to astrogenesis in the
hippocampus that may have contributed to cognitive deficits and memory loss (Garber, Vasek et
al. 2018). Interestingly, transcriptome profiling of NPCs infected with WNV MAD78 and WNV
NY99 in the present study indicated that infections with both viruses downregulated genes
associated with neuron development in the absence of signaling from other cell types (Figure 3.7).
Pro-inflammatory cytokine genes were also upregulated in infected NPCs. The extent of
production of inflammatory cytokines by these cells needs to be determined to see if infected NPCs
control their own differentiation in response to virus infection. Astrocytes infected with MAD78
and NY99 secreted pro-inflammatory cytokines CXCL10, IL-6 and CCL5 (Figure 3.13). The
effect of these cytokines on other neural cell types needs to be assessed.
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Caspase-3-dependent cell death has been implicated as the major contributor to neuronal
death in mice infected with WNV (Samuel, Morrey et al. 2007). Virulent and avirulent WNV
strains differed in their ability to activate caspase-3 in mouse brains following infection and also
differed in which brain regions apoptosis was observed (Donadieu, Lowenski et al. 2013). WNV
NY99 infection of human neurons and NPCs induced caspase-3 cleavage (Figure 3.2A, B).
Treatment of NPCs and neurons with the pan-caspase inhibitor emricasan blocked caspase-3
activation by WNV NY99 infection (Figure 3.2E, F). Interestingly, the levels of infectious virus
produced in neurons treated with emricasan did not decrease at later times post infection while the
levels in untreated neurons decreased. This prolonged production of virus in caspase-inhibited
cells suggests the possibility that persistent infections of these cells by WNV NY99 could be
established. Persistent WNV infection in the spinal cords of mice was previously observed
(Appler, Brown et al. 2010). A single case study of an immunocompetent patient indicated that
persistent infection by WNV in humans is possible (Penn, Guarner et al. 2006). Also, the nonpathogenic WNV MAD78 did not cause significant cleavage of caspase-3 in infected human NPCs
despite efficiently replicating in these cells, suggesting the possibility of a persisting infection with
this WNV strain in NPCs (Figure 3.5C). Future studies should determine the ability of WNV
MAD78 and WNV NY99 to cause persistent infection in CNS cells.
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